SYSTEMATIC REVIEW article

Front. Bioeng. Biotechnol., 01 July 2025

Sec. Biomaterials

Volume 13 - 2025 | https://doi.org/10.3389/fbioe.2025.1611522

The current status of nano-hydrogel preparations for osteochondral repair: Systematic Review

  • 1. Comprehensive Orthopedic Surgery Department, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

  • 2. School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, China

  • 3. Department of Joint Surgery, Honghui Hospital, Xi’an Jiaotong University, Xi’an, Shaanxi, China

Article metrics

View details

4

Citations

3k

Views

608

Downloads

Abstract

Background:

Osteochondral defects, involving both cartilage and subchondral bone, remain clinically challenging due to the poor intrinsic healing capacity of cartilage and the limited durability of traditional treatments. This systematic review aims to evaluate current advancements in nano-hydrogel formulations for osteochondral repair, focusing on their composition, preparation methods, mechanical properties, biocompatibility, and regenerative outcomes.

Methods:

Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a comprehensive literature search was conducted across PubMed, Web of Science, and Scopus. Eligible studies were screened based on predefined inclusion and exclusion criteria. The methodological quality and risk of bias of included studies were assessed using CAMARADES checklist, which considered factors such as randomization, blinding, animal welfare compliance, outcome reporting, and study reproducibility. Data synthesis was performed through structured tabulation and subgroup stratification by scaffold structure (single-phase, bilayered, trilayered, gradient), formulation type (injectable vs. preformed), and polymer origin (natural, synthetic, hybrid).

Results:

A total of 41 studies were included, encompassing both in vitro and in vivo models, with participant numbers ranging from small animal models (e.g., rabbits, rats) to larger preclinical systems. Studies varied in scaffold design, bioactive integration, and fabrication techniques. Most nano-hydrogels demonstrated high biocompatibility, tunable degradation, and enhanced tissue integration. However, heterogeneity in design parameters, lack of standardized outcome measures, and variable reporting quality limited direct comparisons.

Conclusion:

Nano-hydrogels show strong potential as biomimetic scaffolds for osteochondral repair, offering customizable mechanical and biological properties. Nevertheless, the evidence base is limited by study heterogeneity, moderate risk of bias, and lack of standardized protocols, which complicates direct comparison and clinical extrapolation. Future work should focus on long-term validation, functional outcome measures, and development of smart, adaptive materials to support clinical translation.

1 Introduction

Osteochondral defects, characterized by damage to both cartilage and the underlying bone, present a significant clinical challenge due to the limited regenerative capacity of cartilage tissue and the complex architecture of the osteochondral unit (Mano and Reis, 2007; Dinoro et al., 2019; Davis et al., 2021; Liu et al., 2021a). These defects are commonly caused by trauma, osteoarthritis, and other degenerative conditions, leading to pain, reduced mobility, and a decreased quality of life (Verhagen et al., 2003; Martin et al., 2007; Liu et al., 2020). Traditional treatments, such as microfracture surgery, autologous chondrocyte implantation, and osteochondral allografts, often fail to provide long-term solutions, particularly for larger lesions, due to complications such as donor site morbidity, limited graft availability, and incomplete integration with host tissues (Hjelle et al., 2002; Cavendish et al., 2019; Chahla et al., 2019). Consequently, there is a critical need for innovative therapeutic strategies that can effectively promote the regeneration of both cartilage and subchondral bone in a coordinated manner (De Leon-Oliva et al., 2023; Li et al., 2023b).

Recent advances in tissue engineering and regenerative medicine have highlighted the potential of biomaterials to overcome the limitations of conventional therapies (Lynch et al., 2021; Zhang et al., 2021; Cao and Ding, 2022; Luo et al., 2022). Among the various biomaterials explored, nano-hydrogel systems have garnered significant attention due to their unique physicochemical properties and versatility (Chander et al., 2021; Ahmad et al., 2022; Sethi et al., 2023; Rana and De la Hoz Siegler, 2024). Nano-hydrogels are three-dimensional, water-swollen polymeric networks that can be engineered to mimic the native extracellular matrix (ECM) of osteochondral tissues (Liu and Hsu, 2018; Zengin et al., 2021; Hwang and Lee, 2024). Their nano-scale features, high surface area, and tunable mechanical properties make them ideal candidates for supporting cell adhesion, proliferation, and differentiation (Quazi and Park, 2022; Hwang and Lee, 2024). Additionally, nano-hydrogels can be easily functionalized to deliver therapeutic agents, such as growth factors, cytokines, and nanoparticles, in a controlled and sustained manner, further enhancing their regenerative potential (Lee, 2018; Soni et al., 2022).

The design and development of nano-hydrogels for osteochondral repair involve several key considerations, including mechanical strength, biodegradability, biocompatibility, and the ability to support dual regeneration of cartilage and bone (Yue et al., 2020; Xiang et al., 2022; Yao et al., 2023). Successful regeneration requires a scaffold that not only mimics the structural and functional properties of the native tissue but also degrades at a rate that matches the pace of tissue formation, thereby providing support throughout the healing process (Yue et al., 2020; Hwang and Lee, 2024). Furthermore, the incorporation of bioactive molecules that can modulate the local cellular environment is essential for promoting chondrogenic and osteogenic differentiation, ensuring effective integration of the scaffold with host tissues (Yue et al., 2020; Xiang et al., 2022).

While numerous studies have reported the development of nano-hydrogel systems for osteochondral repair, there remains a lack of comprehensive understanding regarding the optimal design parameters and functionalization strategies (Wang et al., 2022b). Additionally, the variability in experimental models and evaluation criteria across studies has made it challenging to compare outcomes and draw definitive conclusions about the efficacy of different approaches (Hwang and Lee, 2024). To address these gaps, this systematic review aims to provide a detailed overview of the current status of nano-hydrogel preparations for osteochondral repair, with a focus on their composition, preparation methods, mechanical properties, biocompatibility, and in vitro and in vivo efficacy.

This review analyzes and synthesizes findings from recent literature, highlighting key advancements and identifying existing challenges in the field. It offers insights into the design principles that guided the development of next-generation nano-hydrogel systems, ultimately contributing to the advancement of more effective and reliable therapeutic solutions for osteochondral defects.

2 Materials and methods

This systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Moher et al., 2009; Moher et al., 2015). A protocol was specified and registered on the database International Prospective Register of Systematic Reviews (PROSPERO) (registration number CRD42024586563) and is available from: https://www.crd.york.ac.uk/prospero/#myprospero.

2.1 Search strategy

A comprehensive search was conducted across three English-language databases: PubMed, Scopus, and Web of Science. The search focused on identifying studies related to nano-hydrogel systems for osteochondral repair. Search terms included combinations of MeSH and free-text keywords: (“nanohydrogel” OR “nanogel” OR “nano-hydrogel scaffold” OR “nanoscale hydrogel” OR “nano-sized hydrogel” OR “nanocomposite hydrogel”) AND (“osteochondral repair” OR “cartilage regeneration” OR “cartilage repair” OR “osteochondral defect”). Filters were applied to include only English-language publications. A detailed list of search terms and strategies for each database is provided in Supplementary Table S1.

Additionally, reference lists of retrieved articles were manually reviewed to identify any further relevant studies. Two authors (AFA and LQ) independently screened titles and abstracts to assess eligibility based on the inclusion criteria. Full-text articles were further reviewed to exclude any duplicates or studies that did not meet the criteria (Figure 1). Discrepancies were resolved through discussion with a third reviewer (JH). The last update search was conducted on 29 September 2024.

FIGURE 1

2.2 Focused question

This systematic review was performed to address the following focused question: “What is the current status of nano-hydrogel preparations in promoting osteochondral repair, specifically regarding their composition, preparation methods, mechanical properties, biocompatibility, and therapeutic efficacy?”

2.3 Selection criteria

To ensure the inclusion of high-quality and relevant studies, specific eligibility criteria were established prior to the screening process. Studies were included if they were original research articles published in peer-reviewed journals, written in English, and focused on the preparation and application of nano-hydrogel systems specifically for osteochondral or cartilage repair. Eligible studies were required to provide sufficient detail on the hydrogel’s composition, crosslinking or functionalization strategies, and report at least one form of biological or functional evaluation, whether in vitro, ex vivo, or in vivo.

Studies were excluded if they were review articles, conference abstracts, dissertations, clinical case reports, editorials, or other forms of grey literature. Additionally, publications that did not focus on osteochondral repair, or those that lacked essential data on hydrogel characterization or biological performance, were omitted. There were no restrictions on publication year; however, only articles published in English were considered. These criteria were designed to ensure methodological rigor and relevance to the focused research question.

2.4 Screening methods and data extraction

Titles and abstracts were screened by two independent reviewers (AFA and LQ), followed by full-text assessments for studies that met the inclusion criteria. Disagreements on study eligibility were resolved through consultation with a third reviewer (JH). The extracting data were following PICO (P: sources, I: interventions, C: control study, O: outcomes) standards.

The data extraction process focused on gathering information about general study characteristics, including nano-hydrogel composition, types of nanoparticles, preparation methods, crosslinking strategies, and controlled release mechanisms. It also covered mechanical and bioactivity properties, such as mechanical strength, degradation rates, biocompatibility, swelling ratios, and functionalization aspects. For in vitro studies, details on cell types, culture conditions, cell viability, and proliferation were collected. In vivo studies were evaluated based on animal models, group allocation, implantation techniques, histological assessments, and outcomes related to subchondral bone and cartilage regeneration, including immunohistochemical findings, inflammation, infection, and hydrogel degradation. Lastly, the extraction included identification of research limitations and recommendations for future studies, ensuring a comprehensive overview of each study’s approach and findings.

2.5 Quality assessment and analysis of the data

The methodological quality of the included studies was evaluated using a customized CAMARADES checklist, which I adapted to better assess the relevance of each study (Macleod et al., 2004). The adapted checklist incorporated 11 key criteria to assess study relevance: (1) publication in a peer-reviewed journal, (2) random allocation to treatment or control groups, (3) blinded outcome assessment, (4) Control of the temperature in the animal facilities, (5) use of appropriate controls, (6) adequate sample size, (7) clear description of the animal model, (8) adherence to animal welfare guidelines, (9) reproducibility and replication of findings, (10) thorough outcome reporting, and (11) disclosure of any potential conflicts of interest. Given the nature of the data, analysis was conducted descriptively, as the variability across studies precluded meta-analysis.

3 Results and discussion

3.1 Search outcomes

Following the removal of duplicates, a total of 1,126 unique publications were identified through database screening. Title and abstract screening narrowed these to 56 articles for full-text evaluation. After applying the inclusion criteria, 11 studies were excluded. Consequently, 41 studies were included in this systematic review (Figure 1). Of these, 34 studies employed both in vitro and in vivo methodologies, while seven were limited to in vitro experiments (Adedoyin et al., 2015; Castro et al., 2015; Kosik-Kozioł et al., 2019; Qin et al., 2020; Fan et al., 2021; Banihashemian et al., 2024; Brown et al., 2024). The assessment of bias showed a spectrum from low to high risk, and detailed findings on methodological quality are illustrated in Figures 2,3, .

FIGURE 2

FIGURE 3

3.2 Nano-hydrogel composition and preparation methods

The studies summarized in Table 1 highlight the structural and compositional diversity of nano-hydrogel systems used for osteochondral repair. These range from simple, single-phase injectable formulations to more complex preformed multilayered scaffolds—each engineered to address distinct mechanical and biological requirements. Scaffold configurations were stratified into single-phase, bilayered, trilayered, and gradient systems. Many bilayered and trilayered constructs were designed to emulate the zonal architecture of osteochondral tissue, allowing site-specific modulation of chondrogenesis and osteogenesis.

TABLE 1

Nano-hydrogel compositionNanoparticles usedFormulation typePolymer originPreparation methods and crosslinking strategiesControlled releaseReferences
Single-phase hydrogel: CuTA@SF hydrogelCu nanoparticlesInjectableNaturalCuTA synthesized by combining Cu nanoparticles with TA; incorporated into SF hydrogel; enzymatically crosslinked using HRP and H2O2TA release from CuTA@SF hydrogel monitored using BCA assayCao et al. (2023)
Bi-layer scaffold: PVA/Col-II/CS (upper), PVA/BCP/CNTs (lower)BCP, CNTsPreformedHybridFreeze–thawing method used to fabricate bi-layer hydrogels, with physical crosslinkingNot explicitly mentionedLan et al. (2021)
Bi-layer scaffold: IL-4-loaded GelMA (upper), PCL-HA (lower)HAPreformedHybridThe bi-layer scaffold was fabricated using two 3D printing techniques: DLP for GelMA and FDM for PCL-HA; physical crosslinking for PCL-HAIL-4 release from GelMA scaffold monitored over 168 hGong et al. (2020)
Trilayered scaffold: GL-HPKGN (upper), GL-GMA (middle), GL-HP/GMAAT (lower)HAPreformedNaturalEnzyme crosslinking for upper layer (KGN-Gelatin), photo-crosslinking for middle layer (GMA-Gelatin), dual-crosslinking for lower layer (Atorvastatin-Gelatin)KGN and AT grafted into the hydrogels, providing sustained releaseChen et al. (2024)
LiMn2O4 nanozyme-functionalized bilayer hydrogel scaffoldLiMn2O4 nanozyme, nHAPreformedHybridCartilage layer crosslinked via UV light; subchondral layer crosslinked by Zn2+ and UV lightLiMn2O4 nanozyme was gradually released, reaching 73.2% release by Day 30Hu et al. (2024)
Bilayered scaffold: top silk fibroin layer; bottom silk-nano (CaP) layerNanoCaPPreformedNaturalSilk-nanoCaP layer prepared with 16 wt% SF and CaP particles; the scaffold was created by salt-leaching and freeze-drying techniquesNot explicitly mentionedYan et al. (2015)
Tri-layer scaffold: Chi/Col I + II/nHAnHAPreformedNaturalFreeze-drying for bone layer; thermal gelation for calcified cartilage and cartilage layersNot explicitly mentionedKorpayev et al. (2020)
Bi-layer scaffold: mPEG-b-PLV thermogelHAPreformedHybridmPEG-b-PLV thermogel was prepared via ring-opening polymerization; PLGA/HA scaffold was prepared via salt-leaching with HA particlesSustained release of KGN from thermogel and BMP-2 from PLGA/HA scaffoldZhang et al. (2022b)
Single-phase hydrogel: p (NiPAAm-co-GMA)/PAMAMFe3O4InjectableSyntheticMixed p (NiPAAm-co-GMA) and PAMAM; dual gelation achieved via thermal and chemical crosslinkingNot explicitly mentionedAdedoyin et al. (2015)
Hybrid scaffold: Zn-AlgMA hydrogel coating DCPD-coated porous Mg alloyZn2+ in the Zn-AlgMAPreformedHybridZn-AlgMA hydrogel prepared using zinc ion crosslinking and UV light crosslinkingControlled release of Mg2+ and Zn2+ from Zn-AlgMAZhang et al. (2024)
Bi-layer scaffold: DE-incorporated GelMADE microparticles (Si ions)PreformedHybridGelMA and DE-incorporated scaffolds fabricated using 3D printing technology; DE microparticles filtered and incorporated into GelMA solutionContinuous release of Si ions from DE microparticlesDeng et al. (2024)
Composite gel containing PCL-chit-PEGb-antiCD44 microparticlesPCL-CS microparticlesInjectableHybridPCL-CS nanofibers prepared by electrospinning, then cryogenically grinded into microparticles, followed by modification with PEG and anti-CD44 antibodyNot explicitly mentionedFilová et al. (2020)
Single- and dual-layer hydrogel–PCL composite scaffold: Heparin-containing PEGDA hydrogelHeparin (sulfated glycosaminoglycan)PreformedHybridHydrogel synthesized with PEGDA, dithiothreitol for hydrolytic degradation; scaffolds printed using selective laser sinteringSustained release of heparin-bound small molecules over 14 daysBrown et al. (2024)
Bi-layer scaffold: Upper (HLC-HA), Lower (HLC-HA-HAP)nHAPreformedNaturalLiquid phase synthesis, freeze-drying, and chemical crosslinking with EDC/NHSNot explicitly mentionedLiu et al. (2021a)
Bi-layer-like: GTU-Fe hydrogel film with spatial in situ deposition of KGN@PDA (top) and miRNA@CaP (bottom)KGN@PDA and miRNA@CaPPreformedNaturalIn situ deposition of drug and gene nanoparticles on the supramolecular-assembled UPy-GelMA hydrogelControlled release of KGN and miR-26a; cumulative release over 7 daysKang et al. (2024)
Bi-layer scaffold: ECM hydrogel-coated ECM/PCL (upper cartilage) + MgO@PDA/PCL (lower bone)MgO nanoparticlesPreformedHybrid3D-printed PCL scaffold incorporating MgO@PDA for the subchondral bone layer and ECM hydrogel for the cartilage layerSustained release of Mg2+ from the MgO@PDALi et al. (2023a)
Bi-layer scaffold: Alginate-nHA with CS-hyaluronic acidnHAPreformedNaturalAlginate and nHA scaffold for subchondral phase; CS-HA scaffold for chondral phase; both layers assembled using fibrin glueNot explicitly mentionedBanihashemian et al. (2024)
Triple-phase hydrogel: In situ synthesized nHA/collagen/alginate hydrogelnHAInjectableNaturalIn situ synthesis of nHAp in collagen gel followed by addition of alginate and crosslinking with Ca2+ ionsNot explicitly mentionedZheng et al. (2014)
Single-phase: Nanosilicate-reinforced silk fibroin (SF-MMT) hydrogelMontmorillonite (MMT)InjectableNaturalEnzymatically crosslinked SF-MMT hydrogel prepared by mixing SF with MMT and crosslinking via HRP and H2O2Not explicitly mentionedSheng et al. (2022)
Single-phase: High-porosity GelMA hydrogel with 5% methacrylated n-HApMA and ADSCsnHA and nHAMAInjectableNaturalSurface modification of nHA using alkylation; bio-inks prepared by incorporating nHAMA and adipose-derived stem cells (ADSCs) into high-porosity GelMANot explicitly mentionedZheng et al. (2023)
Single-phase: GelMA hydrogel loaded with IGF-1 bioactive supramolecular nanofibers (BSN-GelMA)IGF-1 bioactive supramolecular nanofibers (IGF-1bsn)InjectableHybridSupramolecular nanofibers synthesized via solid-phase peptide synthesis; incorporated into GelMA hydrogel using photo-initiator LAPSustained release of IGF-1bsn from hydrogel for enhanced regenerationWu et al. (2023)
Bi-layer scaffold: Double-network hydrogel scaffoldhADSC-derived exosomesPreformedHybrid3D printing with dECM bioinks (Hydrogel-DCM and Hydrogel-DBM) incorporating exosomes; crosslinked with GelMA and HA derivativesSustained release of exosomes from the hydrogel scaffold over 24 daysLi et al. (2023b)
Multileveled hierarchical hydrogel with continuous nHA gradientsSuperparamagnetic HA (MagHA) nanorodsPreformedHybridHydrogel matrix fabricated using 3D printing; MagHA gradient formed under magnetic force; acrylated disodium pamidronate (ADP) used for covalent bonding with GelMA hydrogelNot explicitly mentionedZhang et al. (2023a)
Bilayered hydrogel composed of nHA, CS, and PEGDAnHAPreformedNaturalHydrogels prepared via Schiff-base reaction (CEC + OHA) and PEGDA photocrosslinking for osteochondral scaffold constructionNot explicitly mentionedYou et al. (2018)
Bi-layer scaffold: KGN-loaded GelMA hydrogelHAPreformedNaturalGelMA hydrogels were crosslinked with LAP under UV light; PCL scaffold was 3D printed and coated with HA using alternate soaking technologySustained release of KGN from GelMA hydrogelsZhang et al. (2023b)
Gradient scaffold: Alginate/PVA SIPN hydrogel formed in situnHA and chondroitin sulfateInjectableHybridIn situ semi-interpenetrating network (SIPN) hydrogel with gradient CS and nHA integration via wet chemical precipitation and calcium crosslinkingNot explicitly mentionedRadhakrishnan et al. (2018)
Gradient scaffold: 3D printed gradient nHA hydrogel scaffoldnHAPreformedHybrid3D bioprinting of SA/AM (sodium alginate and acrylamide) hydrogels with CaCl2 crosslinking and gradient nHA loading via electronic spray methodNot explicitly mentionedZhang et al. (2021)
Single-phase: Alginate-GelMA hydrogel with 0.5% β-TCP for modeling calcified cartilageβ-Tricalcium phosphate (TCP)PreformedHybridBioink formulation with 6% GelMA, 4% alginate, and 0.5% TCP microparticles; bioprinted using extrusion-based printing with coaxial needleNot explicitly mentionedKosik-Kozioł et al. (2019)
Single-phase: HGM supramolecular gelatin hydrogel loaded with KGN and/or TGF-β1Not explicitly usedInjectableNaturalHydrogels synthesized using a host-guest macromer approach, with β-cyclodextrin (Ac-β-CD) and GelMASustained release of TGF-β1 and KGN for up to 28 daysXu et al. (2019)
Bi-layer scaffold: Cartilage layer (PLGA/CS hydrogel with tubular pores), Bone layer (nHA-g-PLGA/CS porous scaffold)Grafted nano-hydroxyapatite (nHA-g-PLGA)PreformedHybridPLGA/CS hydrogel for cartilage layer and nHA-g-PLGA/CS scaffold for subchondral bone prepared using electrostatic interaction and crosslinking via EDC/NHSNot explicitly mentionedQin et al. (2020)
Bi-layer scaffold: GC hydrogel (CK2.1/β-GP/CS) for cartilage and LL37@LDH/CS for boneLayered double hydroxide (LDH)PreformedHybridCK2.1 was incorporated into the GC hydrogel; LL37 was loaded into the LDH/CS scaffold using freeze-drying and chemical modification techniquesSustained release of CK2.1 from the GC hydrogelLiu et al. (2021b)
Tri-layer scaffold: CS/Gel/nHAnHAPreformedHybridMultilayer scaffold prepared via iterative layering with crosslinking using NHS/EDCNot explicitly mentionedHu et al. (2022)
Tri-layer gradient scaffold: Gradient nHA hydrogel scaffoldnHAPreformedNaturalFabrication of nHA/GelMA scaffold through 3D printing; multi-layer structure created using sedimentation of nHA and photocrosslinkingNot explicitly mentionedLi et al. (2022)
Biphasic hydrogel composed of BRH and CRHβ-Cyclodextrin nanoboxesInjectableNaturalCRH (HAMA-based) and BRH (GelMA-based) hydrogels prepared via photocrosslinking, with drug nanoboxes for phase-specific deliverySustained release of KGN in the CRH and MLT in the BRHLiu et al. (2020)
Gradient mineralized double-network (DN) hydrogelHAPreformedNaturalHydrogels prepared using a double-network method, with gradient mineralization achieved through a segmented soaking processNot explicitly mentionedFan et al. (2021)
Bi-layer scaffold: Composed of γ-PGA, CMCS, and BCnHAPreformedHybridHydrogel prepared using γ-PGA, CMCS, and BC via chemical and physical crosslinking; bioactive ions (Mg2+ and Cu2+) introduced to cartilage and bone layersSustained release of Mg2+ and Cu2+ for dual regulatory functionsLuo et al. (2022)
Bi-layer scaffold: Mussel-inspired tough hydrogel with in situ nHA mineralizationHAPreformedNaturalBilayer hydrogel prepared using a one-pot method; PDA facilitates in situ HA mineralization for subchondral bone repairSustained release of BMP-2 and TGF-β3 from hydrogel layersGan et al. (2019)
Bi-layer scaffold: PEG-DA hydrogel matrix and nHAnHAPreformedSynthetic3D printing using fused deposition modeling (FDM) to create a biphasic scaffold with nHA in the osseous layer and TGF-β1 in the cartilage layerSustained release of TGF-β1 in the cartilage layer over 21 daysCastro et al. (2015)
Bi-layer scaffold: PLGA and nHAnHAPreformedSyntheticPLGA and PLGA/nHA microspheres were prepared using the oil-in-water emulsion/solvent evaporation methodNot explicitly mentionedShalumon et al. (2016)
Tri-layer scaffold: Injectable and self-healing hydrogel (Ta@gel)TA and HAPreformedHybridInjectable and Ta@gel, combined with 3D-printed HA scaffold; BMSCs encapsulated within GelMA microspheres were loaded into Ta@gelO2 consumption by TA maintains a hypoxic microenvironment for 20 daysGuo et al. (2024)
Single-phase hydrogel: GelMA/Eu-HA nanocomposite hydrogelEu-HA nanorodsInjectableNaturalHydrothermal synthesis of Eu-HA nanorods, incorporated into GelMA hydrogel via UV crosslinkingGradual release of Eu ions from Eu-HA nanorodsJin et al. (2024)

General study information and methods.

BCP, biphasic calcium phosphate; CS, chitosan; DLP, digital light processing; EU-HA, Europium-doped Hydroxyapatite; GelMA, gelatin methacrylate; HRP, horseradish peroxidase; H2O2, hydrogen peroxide; KGN, kartogenin; nHA, Nano-hydroxyapatite; PCL, polycaprolactone; PDA, polydopamine; PEG-DA, polyethylene glycol diacrylate; PLGA, Poly Lactic-co-Glycolic Acid; hADSC, Human Adipose-derived Stem Cells.

Integration of nanoparticles such as hydroxyapatite (HA), chitosan montmorillonite, silica, and polydopamine (PDA) has been shown to enhance the mechanical integrity, osteoconductivity, and cellular interactions of hydrogels (Shalumon et al., 2016; Gong et al., 2020; Korpayev et al., 2020; Sheng et al., 2022; Hu et al., 2024; Jin et al., 2024). For instance, a study by Cao et al. (2023) utilized Cu-based nanoparticles embedded in a silk fibroin (SF) matrix via enzymatic crosslinking to create a single-phase injectable hydrogel with antioxidative and immunomodulatory properties Similarly, preformed bilayer hydrogels composed of polyvinyl alcohol (PVA), biphasic calcium phosphate (BCP), and carbon nanotubes (CNTs) were fabricated through a freeze-thawing process to generate a gradient interface, mimicking native cartilage–bone transition zones (Lan et al., 2021). These examples illustrate how both formulation type and nanoparticle selection directly influence the functional performance of nano-hydrogels.

The choice of crosslinking strategy is another determinant of scaffold performance, affecting mechanical stability, degradation behavior, and cellular response. Studies included a wide array of crosslinking approaches, enzymatic, photo-initiated, thermal, chemical, ionic, and dual-crosslinking methods, each tailored to the specific polymer systems and application needs (Adedoyin et al., 2015; Xu et al., 2019; Zhang et al., 2022b; Cao et al., 2023; Wu et al., 2023; Chen et al., 2024). For instance, photo-crosslinking has been employed to allow spatially controlled gelation, ideal for constructing gradient or multi-layered hydrogels (Zhang et al., 2024). However as highlighted in multiple reports, optimization is needed to reduce cytotoxicity from residual initiators, which may impact cell viability and tissue integration (Berry et al., 2019; Hu et al., 2019; Tomal and Ortyl, 2020). In terms of polymer origin, systems were broadly classified as natural, synthetic, or hybrid. Natural polymers like chitosan, gelatin (GelMA), alginate, and hyaluronic acid offer favorable biocompatibility and degradation profiles. Synthetic polymers such as PEGDA, PVA, and PLGA provide enhanced mechanical tunability and process control. Hybrid systems, which combine the strengths of both natural and synthetic components, emerged as especially promising in balancing bioactivity with structural integrity, several trilayered and bilayered scaffolds utilized such combinations to achieve distinct zone-specific functions.

Moreover, the application of advanced fabrication methods such as 3D printing, electrospinning, microsphere sintering, and solvent casting enabled precise spatial organization of materials. These techniques facilitated the development of functionally graded scaffolds, often incorporating nano-hydroxyapatite (nHA) or exosome-loaded layers, to mimic the mechanical and biochemical gradients of native osteochondral tissue (Zhang et al., 2022b; Brown et al., 2024). Several preformed multilayered systems were constructed with dual or triple layers, each designed with distinct pore architectures, ion release kinetics, and biofunctional molecules to modulate regeneration in a zone-specific manner.

Collectively, the reviewed studies demonstrate how scaffold architecture (e.g., single-phase, bilayered, trilayered), formulation type (injectable vs. preformed), polymer composition (natural, synthetic, hybrid), nanoparticle inclusion, crosslinking strategy, and fabrication technique can be tailored in concert to engineer next-generation nano-hydrogels for osteochondral repair. This multi-dimensional classification, as summarized in Table 1, provides a comparative framework to inform rational scaffold design and translational scaffold development.

3.3 Mechanical properties and degradation behaviour

Mechanical properties are essential for nano-hydrogel systems, particularly for osteochondral repair, where the scaffold must withstand the mechanical stresses of both cartilage and subchondral bone environments. As observed in Table 2, studies report varied mechanical strengths, with compressive moduli ranging from 0.4 MPa (Mpa) to over 73 MPa depending on the hydrogel composition (Gong et al., 2020; Zhang et al., 2022b; Brown et al., 2024; Hu et al., 2024; Kang et al., 2024). For instance, polycaprolactone-hydroxyapatite (PCL-HA) scaffolds have demonstrated compressive moduli as high as 73 ± 1 MPa, while IL-4-loaded GelMA-PCL-HA composites exhibit lower values around 4.7 ± 0.6 MPa (Gong et al., 2020). These scaffold values are within the range of trabecular (cancellous) bone, which exhibits compressive moduli typically between 10 and 200 MPa, depending on site and density. In contrast, the modulus of natural cortical bone is substantially higher, with a longitudinal elastic modulus ranging from 17.2 to 23.2 GPa and a transverse modulus ranging from 10.8 to 13.9 GPa, as demonstrated through multiscale modeling validated by nanoindentation and ultrasound measurements (Hamed et al., 2010). These comparisons highlight the potential of HA-containing scaffolds to approximate native bone behavior in osteochondral repair applications, particularly when enhanced with structural reinforcements like hydroxyapatite.

TABLE 2

Mechanical propertiesDegradation rateDegradation condition (Temp/Env’t)Swelling ratioReferences
Stable mechanical properties; storage modulus (G′) > loss modulus (G″); viscosity increased with TA and CuTA87.9% remained after 70 days in PBSIn an incubatorSwelling equilibrium reached after 72 hCao et al. (2023)
Tensile modulus: 7.14 ± 3 MPa; compression modulus: lower layer (0.081 MPa) > upper layer (0.011 MPa)Slower degradation; upper layer degraded fasterIn an incubatorUpper layer: 586% ± 52%; Lower layer: 151% ± 7.1%Lan et al. (2021)
Compressive modulus: PCL-HA scaffold: 73 ± 1 MPa; IL-4-loaded GelMA-PCL-HA: 4.7 ± 0.6 MPaGelMA hydrogels degraded with 23% mass retention by day 56Body temperatureNot reportedGong et al. (2020)
Shear modulus: Upper layer (54.4 ± 1.2 Pa), Middle layer (700 ± Pa), Lower layer (1,500 ± Pa)Upper layer degraded faster; both biodegradable in collagenaseIn an incubatorUpper layer: 155.3% ± 12.1%; Lower layer: 123.6% ± 11.9%Chen et al. (2024)
Compressive modulus of GH@LM + GA@HLM hydrogel was 73.53 kPaNearly complete degradation by day 30In an incubatorSwelling equilibrium reached after 12 hHu et al. (2024)
Compressive modulus (wet state): 0.4 MPa; storage modulus up to 0.8 MPa27% degradation after 7 days in protease XIV solutionIn an incubatorNot explicitly mentionedYan et al. (2015)
Compressive modulus: Bone layer (42.95 ± 4.3 kPa), calcified cartilage (5.41 ± 0.6 kPa), cartilage (1.49 ± 0.3 kPa)Not explicitly mentionedIn an incubatorNot explicitly mentionedKorpayev et al. (2020)
Compressive modulus of PLGA/HA scaffold: 73.53 kPa; pore size increased during degradationmPEG-b-PLV thermogel showed 48.4% degradation after 30 daysIn an incubatorNot explicitly mentionedZhang et al. (2022b)
Young’s modulus via unconfined compression; suitable for tissue regenerationNot explicitly mentionedIn an incubatorNot explicitly mentionedAdedoyin et al. (2015)
Elastic modulus of Mg scaffold: 0.9–8.8 MPa; Zn-AlgMA improved mechanical stabilityGradual degradation in Hank’s solutionIn an incubatorNot explicitly mentionedZhang et al. (2024)
Elastic modulus increased from 493.3 Pa (GelMA) to 1,010.2 Pa (20% DE); Young’s modulus increased from 64.2 kPa to 122.7 kPaSlower degradation with higher DE concentrationIn an incubatorNot explicitly mentionedDeng et al. (2024)
Higher storage modulus with microparticles than fibrin; loss modulus higher in fibrinNot explicitly mentionedIn an incubatorNot explicitly mentionedFilová et al. (2020)
Compressive strength varies with porosity: 70% (494 kPa), 80% (100 kPa), 90% (20 kPa)Degraded within 4 weeks at 20 mol% DTT concentrationIn an incubatorIncreased fold swelling with higher DTT contentBrown et al. (2024)
Compressive strength: Bilayer (212.11 ± 13.49 kPa) vs. single layer (87.47 ± 13.29 kPa)Not explicitly mentionedIn an incubatorBilayer scaffold: 498.74%; Single-layer: 789.08%Liu et al. (2021a)
Compressive strength of GTU-Fe hydrogel: 2.59 MPa; excellent viscoelasticityGradual degradation; sustained release of KGN and miR-26aIn an incubatorNot explicitly mentionedKang et al. (2024)
Compressive strength: ECM/PCL (0.58 ± 0.02 MPa) and MD/PCL (0.43 ± 0.01 MPa)Gradual Mg2+ ion release over 12 weeks; rapid in first 4 weeksIn water bathNot explicitly mentionedLi et al. (2023a)
Compressive modulus of Alg-nHAP: 0.007 ± 0.0002 MPa; higher in Alg-nHAP/CS-HA51.58% degradation over 15 weeks in PBSIn an incubator10.24-fold increase in swelling over 10 hBanihashemian et al. (2024)
nHCA had highest tensile and compressive modulus compared to othersNot explicitly mentionedIn an incubatorNot explicitly mentionedZheng et al. (2014)
Compression modulus of SF-MMT: 24.78 ± 4.13 kPa; improved viscoelastic propertiesGradual degradation over 91 days in PBSIn an incubatorHigher swelling ratio than SF aloneSheng et al. (2022)
Compression modulus of nHAMA scaffolds was three times higher than controlNot explicitly mentionedIn an incubatorNot explicitly mentionedZheng et al. (2023)
Improved compressive strength of GelMA with IGF-1bsn incorporationGradual degradation over 12 weeks in vivoIn an incubatorNot explicitly mentionedWu et al. (2023)
Improved compressive strength with dual crosslinking; stiffness increasedSlower degradation with DCM/DBM; sustained exosome release over 24 daysIn an incubatorImproved swelling with DCM/DBMLi et al. (2023b)
Compression modulus increased with HA gradient; Young’s modulus correlated with MagHA contentGradual degradation; slower with higher MagHA contentIn an incubatorIncreased swelling with MagHA; faster equilibriumZhang et al. (2023a)
Compressive modulus: SS (subchondral) ∼ 100.09 ± 5.46 kPa, SC (cartilage) ∼ 50.2 ± 1.31 kPaNot explicitly mentionedIn an incubatorSC hydrogel: 53.15%; SS hydrogel: 47.85%You et al. (2018)
Compressive modulus of PCL/HA scaffolds: 14.86 ± 1.81 MPa; enhanced mechanical strengthGelMA hydrogel degraded rapidly; PCL/HA stable over 35 daysIn an incubatorGelMA hydrogels showed rapid swellingZhang et al. (2023b)
Compressive modulus at interfacial region: 930 Pa; increased elastic modulusGradual degradation in vivo; complete defect closure after 8 weeksIn an incubatorNot explicitly mentionedRadhakrishnan et al. (2018)
Compressive strength of gradient scaffold (G-nHA) ∼900 kPa; tensile strength improvedGradual degradation over 28 days in PBSIn an incubatorSwelling equilibrium in 7 h; ratio of 6Zhang et al. (2021)
Compression modulus decreased by 34.5% in TCP-loaded scaffolds; stable viscoelastic propertiesNot explicitly mentionedIn an incubatorSwelling reduced by 18% in TCP-loaded scaffoldsKosik-Kozioł et al. (2019)
Compression modulus enhanced by host-guest interactions; resilient and injectableGradual degradation over 28 daysIn an incubatorHigher swelling ratio than GelMA hydrogelsXu et al. (2019)
Compressive modulus: bone region: 1.95 ± 0.08 MPa; cartilage: 0.85 ± 0.11 MPaNot explicitly mentionedIn an incubatorCartilage region showed high liquid uptakeQin et al. (2020)
Compressive strength: LDH scaffolds: 0.43 MPa; increased to 0.48 MPa with LL37 modificationGradual degradation in vivo after 12 weeksIn an incubatorNot explicitly mentionedLiu et al. (2021b)
Compressive modulus: 0.21–0.53 MPa; optimal scaffolds similar to natural cartilageGradual degradation over 8 weeks in lysozymeIn an incubatorWater absorption varied with compositionHu et al. (2022)
Compressive modulus: 12 kPa (top layer) to 76 kPa (bottom layer)Gradual degradation observed over 8 weeksIn an incubatorNot explicitly mentionedLi et al. (2022)
Compressive modulus: CRH (62.7 kPa), BRH (56.8 kPa); improved with β-CD integrationGradual degradation over 36 days in simulated joint environmentIn an incubatorNot explicitly mentionedLiu et al. (2020)
Compression strength increased with HA concentration; 27 kPa (non-mineralized) to 380 kPa (highly mineralized)Gradual degradation observed over 28 daysIn an incubatorNot explicitly mentionedFan et al. (2021)
Compressive modulus increased from 0.15 MPa to 0.58 MPa with 5% MgSO4Not explicitly mentionedIn an incubatorSwelling rate reduced from 155% to 75%Luo et al. (2022)
Compressive strength: 0.70 MPa; enhanced properties due to PDA and HAGelMA-PDA/HA hydrogels degraded in 19 daysIn an incubatorLow swelling ratio of 180%, minimal distortionGan et al. (2019)
Compression modulus increased by 61% with 60 wt% nHA; ultimate strength increased by 87%Gradual sustained degradation allowing bioactive factor release over 21 daysIn an incubatorNot explicitly mentionedCastro et al. (2015)
Compressive strength: Virgin scaffolds (142 ± 14 MPa), Composite (62 ± 6 MPa), Osteochondral (85 ± 5 MPa)Not explicitly mentionedIn an incubatorNot explicitly mentionedShalumon et al. (2016)
Compressive strength of HAp@PLL scaffold; mechanical strength sustained throughout regenerationHydrogel maintained hypoxic microenvironment for up to 20 daysIn an incubatorNot explicitly mentionedGuo et al. (2024)
Improved mechanical properties with Eu-HA nanorods in GelMA hydrogelGradual degradation in Eu-HA nanocomposite hydrogelIn an incubatorNot explicitly mentionedJin et al. (2024)

Mechanical properties and physical characteristics.

BRH, bone regenerating hydrogel; CRH, cartilage-regenerating hydrogel; EU-HA, Europium-doped Hydroxyapatite; PBS, Phosphate-Buffered Saline; PDA, polydopamine.

Biomimetic designs incorporating GelMA and HA have shown promise in enhancing mechanical stability and bioactivity for bone regeneration applications. GelMA hydrogels, while beneficial for tissue engineering, lack sufficient mechanical strength and osteogenic factors (Wang et al., 2022a). Incorporating HA into GelMA hydrogels improves their mechanical properties, biocompatibility, and osteogenic potential (Suvarnapathaki et al., 2020). Mineralized HA nanofibers further enhance the mechanical and bone regenerative performances of GelMA composites (Wang et al., 2022a). GelMA-based biomaterials can be tailored to overcome challenges in bone tissue engineering, such as insufficient mechanical properties and uncontrolled degradation (Dong et al., 2019). Advanced designs combining GelMA with other materials, like methacrylated HA nanoparticles and l-arginine-based unsaturated poly (ester amide), can create periosteum-mimicking scaffolds with improved mechanical strength, tissue adhesion, and osteogenic-angiogenic coupling effects (Yang et al., 2021). Double-crosslinking and freeze-drying methods have also been widely applied, producing physically and chemically reinforced structures that retain mechanical properties under physiological conditions (Yan et al., 2015; Filová et al., 2020; Zheng et al., 2023).

Balancing degradation rates with tissue regeneration remains another core challenge. An ideal scaffold degrades gradually, transferring mechanical load to newly forming tissue to aid integration (Hu et al., 2022; Li et al., 2022; Banihashemian et al., 2024; Chen et al., 2024). Studies have shown that adjusting crosslinking density and introducing bioactive molecules can customize degradation profiles for specific applications (Radhakrishnan et al., 2018; Zhang et al., 2023a; Zhang et al., 2023b; Deng et al., 2024). For example, Chen et al. developed a trilayered hydrogel with varied degradation rates across layers to replicate the native tissue gradient from cartilage to bone, facilitating sustained cell infiltration and extracellular matrix formation (Chen et al., 2024). Recent research has focused on developing multilayered hydrogel scaffolds to mimic the zonal organization of native cartilage tissue. These scaffolds feature gradients in mechanical properties, extracellular matrix composition, and bioactive factors across layers to guide cell differentiation and tissue formation (Brady et al., 2017; Qiao et al., 2021). Furthermore, a study demonstrated that layer-specific biomaterial compositions could direct a single stem cell population into zone-specific chondrocytes, resulting in native-like cartilage with varying mechanical and biochemical properties (Nguyen et al., 2011). In addition, a study further showed that stiffness gradient hydrogels could induce zone-specific responses in both chondrocytes and mesenchymal stem cells, mimicking cartilage zonal organization (Zhu et al., 2018). These approaches offer promising strategies for engineering complex osteochondral tissues with spatially-varying properties that more closely resemble native tissue structure and function.

Future advancements will likely focus on refining crosslinking techniques, such as enzyme-catalyzed, thermal, and photo-crosslinking, to develop materials that meet both mechanical and degradation needs for effective tissue engineering.

3.4 Biocompatibility and functional characteristics

Nano-hydrogel systems have consistently demonstrated excellent biocompatibility and functional characteristics, making them highly suitable for applications in tissue engineering, particularly in osteochondral regeneration. Studies have reported cell viability rates exceeding 90% and enhanced cell proliferation, supporting the potential of these materials to promote tissue growth and regeneration (Table 3). For example, a study showed that LiMn2O4 nanozyme-functionalized hydrogels effectively supported the proliferation of rat chondrocytes and bone marrow-derived mesenchymal stem cells (BMSCs), promoting cell adhesion and growth (Hu et al., 2024). In addition, in vitro studies have highlighted that nano-hydrogels, such as GH@LM + GA@HLM and Zn-AlgMA, significantly enhance the proliferation of both chondrocytes and BMSCs, while maintaining high levels of cell viability (Hu et al., 2024; Zhang et al., 2024). Similarly, functionalized scaffolds, including those with CK2.1/LL37 and SF-MMT, further promote the regenerative processes of BMSCs and chondrocytes, reinforcing the critical role of scaffold composition in optimizing cellular responses (Liu et al., 2021b; Sheng et al., 2022).

TABLE 3

Cell types usedCulture conditionsViability and proliferationBioactivityFunctionalization and targetingReferences
BMSCs, chondrocytesDMEM with 10% FBS, 1% Penicillin/Streptomycin; osteogenic and inflammatory induction>90% viability; enhanced proliferation in CuTA@SFPromoted osteogenesis and chondrogenesisTargeted osteochondral regeneration, cartilage and bone repairCao et al. (2023)
MC3T3-E1 cells, chondrocytesMedia leached from hydrogel layers over 7 days>90% viability; enhanced proliferation for both cell typesPromoted osteogenesis and chondrogenesisTargeted osteochondral regenerationLan et al. (2021)
L929 fibroblasts, C3H mouse MSCs, mouse chondrocytesDMEM/F12 with IL-4; osteogenic induction media for MSCs>97% viability; no significant difference in growthPromoted anti-inflammatory effects, and chondrogenesisTargeted osteochondral regenerationGong et al. (2020)
rBMSCsCultured with KGN and AT in induction media for 14 days>95% viability; good proliferation confirmedEnhanced chondrogenesis and osteogenesisTargeted for osteochondral regenerationChen et al. (2024)
Rat chondrocytes, BMSCsTreated with ROS inducer H2O2>95% viability; high proliferationEnhanced chondrogenesis and osteogenesisDesigned for osteochondral repairHu et al. (2024)
rBMSCsCultured in basal and osteogenic media for up to 14 days>90% viability; increase in proliferation over 14 daysEnhanced osteogenesis in silk-nanoCaP layerTargeted osteochondral repair with distinct layersYan et al. (2015)
MC3T3-E1 preosteoblasts, ATDC5 chondrocytesCo-cultured in layers for 7 days, then 21 days>85% viability; significant increase in metabolic activityEnhanced chondrogenesis (COL II) and osteogenesis (COL I, ALP)Designed for osteochondral repairKorpayev et al. (2020)
BMSCsCultured in thermogel layer with KGNHigh viability maintainedEnhanced chondrogenesis and osteogenesisFull-thickness osteochondral repairZhang et al. (2022b)
WRN cellsEncapsulated in hydrogels with Fe3O4 nanoparticles for 48 hHigh viability; no cytotoxicityFe3O4 nanoparticles exert physiological forces on encapsulated cellsInjectable scaffolds for osteochondral regenerationAdedoyin et al. (2015)
BMSCsCultured in osteogenic and chondrogenic media with immersion liquid>90% viability; proliferation in Zn-AlgMA hydrogel at 10−4 M zinc ionEnhanced osteogenesis (Mg2+) and chondrogenesis (Zn2+)Targeted osteochondral repairZhang et al. (2024)
rBMSCs and chondrocytesCultured on GelMA and DE-incorporated scaffolds in induction mediaHigh cell viability observed on 5%–20% DE scaffoldsDE microparticles significantly enhanced chondrocyte proliferationDual-layer scaffolds for cartilage and bone regenerationDeng et al. (2024)
Fibrochondrocytes, chondrocytesCultured on PCL-chitosan and anti-CD44-modified microparticlesHigh viabilityAnti-CD44 microparticles enhanced osteogenic regenerationTargeted osteochondral defectsFilová et al. (2020)
Porcine chondrocytesEncapsulated in PEGDA-DTT hydrogels for 7 days>95% viabilityHeparin promoted sustained release and enhanced differentiationCraniofacial reconstruction, supporting cartilage and boneBrown et al. (2024)
hBMSCsCultured in scaffolds with DMEM and supplementsHigh viability confirmedEnhanced chondrogenesis and osteogenesisTargeted osteochondral defect repairLiu et al. (2021a)
MSCs and chondrocytesCultured in hydrogel scaffoldsHigh viability confirmedEnhanced chondrogenesis and osteogenesisTargeted osteochondral regenerationKang et al. (2024)
hBMSCsCultured on ECM/PCL and MD/PCL scaffoldsHigh viability confirmedECM/PCL promoted huBMSC proliferationTargeted osteochondral defectsLi et al. (2023a)
hCHCs and hAdMSCsCultured in CS-HA and Alg-nHAP scaffoldsHigh viabilitySignificant proliferation in both scaffold typesTargeted osteochondral repairBanihashemian et al. (2024)
Chondrocytes from newborn rabbitEncapsulated in nHCA, HCA, and nHC hydrogels for 21 daysHigh viabilitynHCA showed highest cell proliferationTargeted osteochondral regenerationZheng et al. (2014)
BMSCs and chondrocytesCultured in SF-MMT and SF with osteogenic induction>93% viabilityIncreased proliferation with no significant differenceTargeted osteochondral regenerationSheng et al. (2022)
ADSCsCultured in nHAp and nHApMA bio-inksHigh viability confirmedEnhanced osteogenic and chondrogenic differentiationTargeted osteochondral regenerationZheng et al. (2023)
rBMSCsCultured in GelMA and GelMA/IGF-1bsn hydrogels for 72 hHigh viability confirmedBSN-GelMA significantly enhanced rBMSC proliferationOsteochondral regeneration in mosaicplastyWu et al. (2023)
rBMSCsCultured in Hydrogel-DCM and Hydrogel-DBM for 14 daysHigh viability confirmedExosome-loaded scaffolds enhanced proliferationTargeted osteochondral repairLi et al. (2023b)
BMSCsCultured in MagHA-gradient hydrogel for 21 daysHigh viability confirmedSignificant proliferation in MagHA gradient compared to controlFull-thickness osteochondral regenerationZhang et al. (2023a)
rBMSCsEncapsulated in SC and SS hydrogels>90% viabilitySignificant proliferation in both hydrogelsDesigned for osteochondral regenerationYou et al. (2018)
BMSCsCultured in KGN-loaded GelMA and HA-coated PCL scaffoldsHigh viability confirmedSignificant proliferation in both cartilage and bone regionsTargeted osteochondral repairZhang et al. (2023b)
Rat osteoblasts and caprine chondrocytesCo-cultured in gradient hydrogel for 21 daysHigh viability confirmedHigher proliferation in nHA-enriched hydrogelsDesigned for osteochondral regenerationRadhakrishnan et al. (2018)
Goat TMJ disc cellsCultured in nHA-gradient hydrogels; assessed via MTT and AO/EB stainingHigh viability confirmedIncreased proliferation in G-nHA scaffold compared to controlsTargeting cartilage and subchondral bone with gradient layersZhang et al. (2021)
BM-hMSCsCultured in chondrogenic media for 21 daysHigh viability confirmedIncreased proliferation in TCP-loaded scaffoldsDesigned for calcified cartilage and subchondral bone regenerationKosik-Kozioł et al. (2019)
hBMSCsEncapsulated in HGM and GelMA hydrogels with TGF-β1 or KGN for 14 days>95% viabilitySignificant proliferation in HGM compared to GelMAInjectable for osteochondral regenerationXu et al. (2019)
hASCsSeeded into bilayer scaffold with BMP-2 and IGF-1 for 14 daysHigh viability observedCells proliferated and formed spheroids in cartilage regionSequential chondrogenesis and osteogenesis mimicking natural tissueQin et al. (2020)
MSCs and HUVECsCultured in CK2.1/LL37-loaded scaffolds for 14 daysHigh viability observedEnhanced proliferation in CK2.1/LL37 scaffoldsTargeting cartilage and subchondral boneLiu et al. (2021b)
ADSCsCultured in multilayer scaffolds in static and dynamic environments>90% viabilityHigher proliferation in dynamic culture compared to staticLayered design for cartilage and subchondral bone targetingHu et al. (2022)
BMSCsCultured in multi-layer scaffold in osteogenic and chondrogenic media>95% viabilitySignificant proliferation in both regionsTargeting cartilage and subchondral bone in distinct layersLi et al. (2022)
hMSCsEncapsulated in CRH and BRH hydrogels for 21 days>90% viabilitySignificant proliferation with phase-specific differentiationSimultaneous regeneration of cartilage and subchondral boneLiu et al. (2020)
BMSCsCultured in gradient mineralized hydrogels for 21 days>95% viabilityGood proliferation in non-mineralized and mineralized layersMimicking cartilage and subchondral bone regions with gradientsFan et al. (2021)
BMSCsCultured in Mg2+- and Cu2+-regulated layersHigh viability observedEnhanced proliferation in regulated hydrogelsDesigned for osteochondral regenerationLuo et al. (2022)
BMSCs and chondrocytesCultured on GelMA, GelMA-PDA, and GelMA-PDA/HAHigh viability confirmedSignificant proliferation in PDA-incorporated hydrogelsTargeting cartilage and subchondral bone in dual-layer structureGan et al. (2019)
hMSCsCultured on PEG-DA scaffolds with nHA and TGF-β1High viability; significant proliferation observed93% and 53% increase for 40 wt% and 60 wt% nHADesigned for osteochondral regenerationCastro et al. (2015)
BMSCs and chondrocytesBMSCs in osteogenic medium, chondrocytes in chondrogenic medium>90% viabilitySignificant proliferation in both partsDesigned for osteochondral tissue engineeringShalumon et al. (2016)
BMSCs and chondrocytesEncapsulated in GelMA microspheres in induction media>90% viabilitySignificant proliferation; enhanced differentiation confirmedTargeting cartilage and subchondral bone for complex regenerationGuo et al. (2024)
Chondrocytes, BMSCs, RAW264.7 macrophagesCultured in DMEM/F12, α-MEM, and DMEM with 10% FBS>90% viabilityPromotion of chondrocyte proliferation and BMSC differentiationDesigned to facilitate immunomodulation for osteochondral regenerationJin et al. (2024)

Biocompatibility and functional characteristics.

BMSCs, Bone Marrow Mesenchymal Stem Cells; hBMSCs, Human Bone Marrow Mesenchymal Stem Cells; rBMSCs, rabbit Bone Marrow Mesenchymal Stem Cells; BM-hMSCs, Bone Marrow-Derived Human Mesenchymal Stem Cells; hMSCs, Human Mesenchymal Stem Cells; TMJ, temporomandibular joint; hCHCs, Human Chondrocyte-like Cells; hAdMSCs, Human Adipose-derived Mesenchymal Stem Cells; WRN, wnt rspondin noggin cells; hASCs, Human adipose-derived stem cells.

Nano-hydrogels mimicking the extracellular matrix (ECM) have emerged as promising scaffolds for tissue engineering and regenerative medicine. These biomimetic materials create a three-dimensional (3D) environment that closely resembles the native ECM’s nanoscale architecture (Geckil et al., 2010; Gough et al., 2012; Brown et al., 2024). By incorporating nanostructured components, such as nanofibers or nanosilicates, these hydrogels can actively modulate cellular responses, including attachment, proliferation, and differentiation (Wei and Ma, 2008). For instance, nanoengineered collagen-based hydrogels reinforced with disk-shaped nanosilicates have been shown to enhance osteogenic differentiation of human mesenchymal stem cells without the need for exogenous growth factors (Paul et al., 2016). These ECM-mimicking hydrogels not only provide structural support but also create a regulatory milieu that guides tissue formation and organization (Geckil et al., 2010). Furthermore, their biocompatibility and ability to induce regenerative processes make them promising candidates for various biomedical applications, including bone tissue engineering and in vitro disease modeling (Wei and Ma, 2008; Paul et al., 2016).

Furthermore, functionalization techniques are crucial for enhancing the bioactivity of hydrogels in osteochondral tissue engineering. By incorporating growth factors, bioactive molecules, and nanoparticles, these hydrogels can promote both osteogenesis and chondrogenesis. For example, research has shown that embedding polydopamine-encapsulated kartogenin (KGN) and calcium phosphate-encapsulated miRNA-26a within hydrogels effectively promotes regeneration in both cartilage and bone layers (Kang et al., 2024). Additionally, KGN has been grafted onto ultrasmall superparamagnetic iron-oxide nanoparticles, which are then integrated into hydrogels for cartilage repair while enhancing MRI contrast (Yang et al., 2019). Another study developed microscaffold-hydrogel composites containing KGN and peptides to accelerate osteochondral repair through endochondral ossification (Zhang et al., 2022a). Moreover, a versatile hydrogel system using click chemistry has been created to provide tissue-specific cues for either chondrogenesis or osteogenesis (You et al., 2018; Guo et al., 2020; Liu et al., 2021a; Li et al., 2023a). These approaches highlight the potential of functionalized hydrogels in addressing the complex requirements of osteochondral tissue regeneration.

Recent studies demonstrate the effectiveness of functionalized biomaterials in advancing osteochondral repair, primarily by supporting both osteogenic and chondrogenic differentiation. Composite hydrogels with anti-CD44-labeled microparticles have shown to significantly improve osteogenic regeneration in animal models of osteochondral defects (Filová et al., 2020). Likewise, bilayer scaffolds that guide stem cell differentiation spatially have been effective in directing cells into osteogenic and chondrogenic lineages, enhancing repair outcome (Kang et al., 2024; Lowen et al., 2024). Furthermore, microscaffold-hydrogel composites, incorporating bioactive modifications like RGD peptides, have demonstrated accelerated osteochondral repair through endochondral ossification, achieved by controlled delivery of bioactive molecules within the scaffold layers (Zhang et al., 2022a; Brown et al., 2024; Deng et al., 2024). Other studies reinforce these findings, with functionalized hydrogels designed for dual osteogenic and chondrogenic applications showing sustained, layer-specific release of growth factors and bioactive ions, thus promoting cell proliferation and tissue integration (Cao et al., 2023; Wu et al., 2023).

These findings underscore the potential of multi-functionalized nano-hydrogels in tissue engineering, with customizable layers enabling the spatially controlled release of bioactive agents that foster site-specific tissue regeneration. Such approaches pave the way for advanced therapies for osteochondral defects and other complex tissue engineering applications (Wu et al., 2023; Brown et al., 2024).

These findings suggest that nano-hydrogels are capable of providing a supportive 3D microenvironment that mimics the native ECM. However, achieving consistent differentiation and integration remains challenging, particularly when translating in vitro success to in vivo conditions. Variability in cell behavior across studies suggests that more standardized protocols are needed to optimize cell-scaffold interactions, ensuring predictable outcomes in clinical settings.

3.5 In vivo efficacy and regeneration outcomes

The in vivo studies summarized in Table 4 illustrate the promising efficacy of nano-hydrogels in promoting osteochondral repair, using diverse animal models such as rabbits, rats, and mice to assess the regenerative potential of these systems. Significant cartilage regeneration and subchondral bone repair were observed in a rabbit model using a bi-layered GelMA-PCL-HA scaffold, where histological analyses confirmed the formation of a smooth cartilage surface and well-integrated bone layer (Gong et al., 2020). Similarly, a bilayer hydrogel containing GH@LM + GA@HLM demonstrated notable regeneration, with micro-CT and histological assessments indicating smooth hyaline cartilage formation and robust subchondral bone repair (Hu et al., 2024) (Table 4). These advanced hydrogel systems have demonstrated improvements in defect filling, cartilage thickness, and bone regeneration compared to control groups (Gan et al., 2019; Guo et al., 2021). However, a critical review of in vivo cartilage repair studies highlights the need for standardized experimental designs and careful interpretation of results (Vilela et al., 2015).

TABLE 4

Animal modelGroup allocationImplantation methodHistological assessmentReferences
Rabbits5 groups: Control, SF, Cu@SF, TA@SF, CuTA@SFPre-formed hydrogels implanted into OCD siteCuTA@SF showed the best integration and cartilage repairCao et al. (2023)
Rabbits3 groups: Blank, PVA hydrogel, Bi-layer hydrogelHydrogels implanted into defects created in rabbit kneesBi-layer group showed better cartilage and bone repairLan et al. (2021)
Rabbits3 groups: Nontreated, bi-layer scaffold, and IL-4-loaded bi-layer scaffold; 8- and 16-week post-surgery observationsBi-layer scaffold implanted into defects created in rabbit knee jointsIL-4-loaded scaffold group showed better cartilage repairGong et al. (2020)
Rabbits3 groups: Untreated (blank), control, experimentalTrilayered scaffolds implanted into osteochondral defectsExperimental group showed better cartilage and bone repairChen et al. (2024)
Sprague-Dawley rats4 groups: PBS, GH + GA (basic hydrogel), GH + GA@H (with nanohydroxyapatite), GH@LM + GA@HLM (with nanozyme)Bilayer hydrogels implanted into femoral condyle defectsGH@LM + GA@HLM showed the best cartilage and subchondral bone repairHu et al. (2024)
Rabbits2 groups: bilayered scaffold implantation and defect control (no scaffold)Bilayered scaffolds were press-fit into osteochondral defects in rabbit kneesScaffold showed cartilage and subchondral bone regenerationYan et al. (2015)
BALB/c miceSpecific details are not explicitly mentionedMulti-layered scaffolds were inserted into subcutaneous pockets created in miceStaining showed mild inflammatory response with macrophage and neutrophil infiltrationKorpayev et al. (2020)
Rabbits4 groups: control, Gel/Scaffold, Gel-MSCs/Scaffold, GelKGN-MSCs/ScaffoldBMP-2Bilayered scaffolds were implanted into osteochondral defects in the femoral condyleStaining showed cartilage and subchondral bone regeneration in the GelKGN-MSCs/ScaffoldBMP-2 groupZhang et al. (2022b)
Rabbits4 groups: blank control, Zn-AlgMA, DCPD-coated Mg, Zn-AlgMA@Mg scaffoldScaffolds implanted into osteochondral defects in femoral condylesZn-AlgMA@Mg group showed best osteochondral integrationZhang et al. (2024)
Rabbits4 groups: blank control, GelMA, 0–10 DE, 5–20 DE scaffoldsScaffolds implanted in femoral condyle defects5–20 DE group showed best osteochondral regenerationDeng et al. (2024)
Rabbits3 groups: scaffold #1 (PCL-chit-PEGb), scaffold #2 (PCL-chit-PEGb-antiCD44), controlScaffolds implanted in femoral condyle defectsPCL-chit-PEGb showed superior hyaline cartilage regeneration, while anti-CD44 favored bone formationFilová et al. (2020)
Rabbits3 groups: Control, single-layer scaffold, bilayer scaffoldBilayer scaffolds implanted into knee joint defectsBilayer scaffold showed better cartilage regeneration and bone formationLiu et al. (2021a)
Rabbits5 groups: Control, GTU-Fe, GTU-Fe/KGN@PDA, GTU-Fe/miRNA@CaP, GTU-Fe/KGN@PDA/miRNA@CaPCylindrical GTU-Fe scaffolds implanted into knee defectsGTU-Fe/KGN@PDA/miRNA@CaP showed better cartilage and bone regenerationKang et al. (2024)
Rats5 groups: Blank, PCL, ECM/PCL, MD/PCL, Bilayer scaffoldBilayer scaffolds implanted into knee joint defectsBilayer scaffold showed better cartilage and bone regenerationLi et al. (2023a)
Rabbits3 groups: Control, SF hydrogel, SF-MMT hydrogelSF and SF-MMT hydrogels implanted into osteochondral defects in rabbit kneesSF-MMT showed better cartilage and bone regenerationSheng et al. (2022)
Rabbits3 groups: Control, nHAp bio-ink, nHApMA bio-inkScaffolds implanted into femoral condyle defects in rabbit kneesnHApMA showed better cartilage and bone regenerationZheng et al. (2023)
Rabbits3 groups: Blank, GelMA hydrogel, BSN-GelMA hydrogelMosaicplasty performed on rabbit knee jointsBSN-GelMA showed better gap integration and tissue regenerationWu et al. (2023)
Rats4 groups: Blank, Hydrogel, Bi-Hydrogel, Bi-Hydrogel-ExosBilayer scaffolds implanted into osteochondral defects in rat knee jointsBi-Hydrogel-Exos showed better osteochondral regenerationLi et al. (2023b)
Rabbits5 groups: Control, DN hydrogel, bi-phasic hydrogel, MagHA gradient hydrogel with (Gra+) and without (Gra-) magnetic field stimulationHydrogel scaffolds implanted into rabbit knee joint defectsMagHA-gradient hydrogel showed enhanced osteochondral regeneration, especially in Gra+Zhang et al. (2023a)
C57BL/6J miceSpecific details are not explicitly mentionedSC and SS hydrogels implanted under dorsal skinStaining showed good integration of hydrogels with surrounding tissueYou et al. (2018)
Rabbits4 groups: Blank, PCL/GelMA, PCL/GelMA@TA/E7, PCL/HA-GelMA/KGN@TA/E7Bilayer scaffolds implanted into knee joint defectsPCL/HA-GelMA/KGN@TA/E7 group showed better cartilage and subchondral bone regenerationZhang et al. (2023b)
Rabbits4 groups: Control, nHA scaffold, ChS scaffold, Gradient (nHA + ChS) scaffoldHydrogels injected into osteochondral defects in rabbit kneesGradient scaffold group showed improved collagen and GAG depositionRadhakrishnan et al. (2018)
Rats7 groups: Control, BMSCs only, 0% nHA + BMSCs, 40% nHA + BMSCs, 70% nHA + BMSCs, G-nHA only, G-nHA + BMSCsScaffolds implanted into rat knee defectsG-nHA + BMSCs group showed better osteochondral regenerationZhang et al. (2021)
Rats4 groups: GelMA with KGN, GelMA with TGF-β1, HGM (Injection) with KGN, HGM (Injection) with TGF-β1HGM hydrogels injected into defects in rat kneesHGM groups showed better cartilage and subchondral bone regenerationXu et al. (2019)
Rabbits3 groups: Control, biphasic scaffold without peptide (GC/LC), biphasic scaffold with CK2.1/LL37 (CK2.1@GC/LL37@LC)Scaffolds implanted into osteochondral defectsCK2.1/LL37 group showed better cartilage and subchondral bone regenerationLiu et al. (2021b)
Rabbits4 groups: Negative control, positive control, static scaffold group, dynamic scaffold groupMultilayer scaffolds implanted into knee defects in rabbitsDynamic scaffold showed better osteochondral regeneration compared to the static groupHu et al. (2022)
Rabbits3 groups: Control, GelMA scaffold, nHA-GelMA scaffoldScaffolds implanted into osteochondral defects in rabbit knee jointsnHA-GelMA showed better osteochondral regenerationLi et al. (2022)
Rabbits4 groups: Control, Drug-free BRH-CRH, BRH-CRH (no MSCs), BRH-CRH [MSC-encapsulated]Bilayer BRH-CRH hydrogel scaffolds injected osteochondral defect siteBRH-CRH [MSC-encapsulated] showed better osteochondral integration and cartilage regenerationLiu et al. (2020)
Rabbits3 groups: Control, DN material group, DN-3Mg/Cu hydrogel groupBilayer hydrogels implanted into osteochondral defects in rabbitsDN-3Mg/Cu hydrogel showed better osteochondral regenerationLuo et al. (2022)
Rabbits3 groups: Pure GelMA, bilayer GelMA-PDA/HA, bilayer GelMA-PDA/HA with BMP-2 and TGF-β3Bilayer hydrogels implanted into osteochondral defects in rabbit knee jointsBMP-2/TGF-β3 showed well-organized cartilage and subchondral bone regenerationGan et al. (2019)
Nude mice2 groups: Acellular scaffold and cell-seeded scaffold (sample)Cell-seeded scaffolds implanted subcutaneously in nude miceStaining confirmed tissue-specific regeneration of bone and cartilage in scaffoldsShalumon et al. (2016)
Rabbits4 groups: HAp@PLL scaffold, Ta@gel + GelMA@BMSCs, HAp@PLL + hydrogel + GelMA@BMSCs, and HAp@PLL + Ta@gel + GelMA@BMSCsComposite scaffolds were implanted in 4 mm osteochondral defects in rabbit knee jointsHAp@PLL + Ta@gel + GelMA@BMSCs revealed better osteochondral regenerationGuo et al. (2024)
Rats4 groups: Control, GelMA, GelMA/HAp, and GelMA/Eu-HApGelMA/Eu-HAp hydrogel was injected into osteochondral defectsGelMA/Eu-HAp showed better cartilage and bone regenerationJin et al. (2024)
ImmunohistochemistryInflammation and infectionDegradation of hydrogelReferences
Strong positive staining for COL I and AGG in both cartilage and subchondral bone regions in CuTA@SF groupNo signs of infectionCuTA@SF degraded almost completely by week 12 than other groupsCao et al. (2023)
Positive staining for COL I and COL II in cartilage and subchondral bone regions, indicating successful tissue repairNo signs of infectionUpper layer degraded faster than lower; neither layer completely degraded after 12 weeksLan et al. (2021)
Positive COL2 staining in IL-4 scaffold group, indicating cartilage regenerationNo signs of infectionGelMA layer showed gradual degradation over 16 weeksGong et al. (2020)
COL2 and OCN staining showed significant matrix deposition in cartilage and bone regions in the experimental groupNo signs of infectionGradual degradation of scaffolds over 12 weeks; KGN and AT released during scaffold degradationChen et al. (2024)
Strong COL II and Aggrecan in cartilage, COL I and Opn in bone for GH@LM + GA@HLM groupNo signs of infectionGH@LM + GA@HLM hydrogel gradually degraded over 12 weeksHu et al. (2024)
Positive staining for collagen II in cartilage and new bone formation in the silk-nanoCaP layerNo signs of infectionScaffold maintained integrity with no significant mass loss over 4 weeksYan et al. (2015)
Not reportedInflammation noted at the scaffold interfaceNot explicitly mentionedKorpayev et al. (2020)
Positive staining for COL II in cartilage and COL I in subchondral bone confirmed tissue regenerationMinimal inflammation observedScaffold and thermogel gradually degraded over 3–6 monthsZhang et al. (2022b)
Positive COL II staining in cartilage and COL I staining in bone confirmed tissue regenerationNo signs of infectionGradual degradation of the Zn-AlgMA hydrogel and Mg alloy over the course of the 10-week studyZhang et al. (2024)
Positive COL II and COL I staining confirmed cartilage and bone tissue regeneration in 5–20 DE scaffoldsNo signs of infectionSlower degradation observed in DE-incorporated scaffolds, with 5–20 DE showing the slowest rateDeng et al. (2024)
COL II and osteocalcin revealed scaffold #1 (PCL-chit-PEGb) promoted cartilage, while scaffold #2 (anti-CD44) favored bone formationanti-CD44 exhibited more inflammatory infiltrationNot explicitly mentionedFilová et al. (2020)
Positive staining for COL I and COL II confirmed cartilage and bone tissue regenerationNo signs of infectionNot explicitly mentionedLiu et al. (2021a)
Positive staining for COL II and COL I confirmed tissue regenerationNo signs of infectionGradual degradation observed over 12 weeks post-implantationKang et al. (2024)
Positive staining for COL II in cartilage and COL I in subchondral bone confirmed tissue regenerationNo signs of infectionGradual degradation of the scaffold over 12 weeks, with sustained Mg2+ releaseLi et al. (2023a)
Positive staining for Aggrecan and COL II confirmed cartilage matrix formation in SF-MMT groupNo signs of infectionGradual degradation of the SF-MMT hydrogel over the course of the 12-week studySheng et al. (2022)
Positive staining for Runx2 and Sox9 confirmed osteogenic and chondrogenic differentiation in nHApMA scaffoldsNo signs of infectionNot explicitly mentionedZheng et al. (2023)
Positive staining for collagen II confirmed enhanced cartilage regeneration in BSN-GelMA groupNo signs of infectionGradual degradation observed over 12 weeksWu et al. (2023)
Positive staining for COL II in cartilage and COL I in bone confirmed tissue regenerationNo significant inflammation observed in any groupGradual degradation over 12 weeks, with good scaffold integrationLi et al. (2023b)
Positive staining for collagen II in cartilage and collagen I in bone confirmed tissue regeneration in MagHA groupsNo signs of infectionGradual degradation observed over 12 weeks; slower in MagHA-rich regionsZhang et al. (2023a)
Not applicableNo signs of infectionNot explicitly mentionedYou et al. (2018)
Positive staining for COL II in cartilage and COL I in bone confirmed tissue regenerationNo signs of infectionGradual degradation of GelMA observed over 12 weeksZhang et al. (2023b)
Not reportedNo signs of infectionGradual degradation observed over 8 weeksRadhakrishnan et al. (2018)
Positive COL II staining confirmed cartilage regeneration in G-nHA + BMSCs groupNo signs of infectionGradual degradation of the scaffold over 12 weeks post-implantationZhang et al. (2021)
Positive staining for type II collagen confirmed chondrogenesis in HGM groupsNo signs of infectionGradual degradation of HGM hydrogels over 6 weeksXu et al. (2019)
Positive staining for COL I in subchondral bone and COL II in cartilage confirmed tissue regenerationNo signs of infectionGradual degradation observed over 12 weeks post-implantationLiu et al. (2021b)
Positive staining for COL II confirmed cartilage matrix formation in dynamic groupNo signs of infectionGradual degradation of the scaffold observed over 12 weeksHu et al. (2022)
Positive staining for COL II in cartilage and COL I in subchondral bone confirmed tissue regenerationNo signs of infectionGradual degradation over 12 weeksLi et al. (2022)
Positive staining for COL II in cartilage and COL I in bone confirmed phase-specific tissue regenerationNo signs of infectionGradual degradation observed over 12 weeks in vivoLiu et al. (2020)
Positive staining for type II collagen and GAG in cartilage, and collagen type I in bone in DN-3Mg/Cu groupNo signs of infectionGradual degradation observed over 12 weeksLuo et al. (2022)
Not reportedNo signs of infectionGradual degradation over 12 weeksGan et al. (2019)
Positive staining for type I collagen (bone) and type II collagen (cartilage) confirmed osteochondral tissue formationNo signs of infectionNot explicitly mentionedShalumon et al. (2016)
Positive staining for COL II, ACAN, and SOX9 in cartilage, and COL I, OPN, and OCN in subchondral boneNo signs of infectionGradual degradation of hydrogel observed, supporting tissue regenerationGuo et al. (2024)
Positive staining for CD206 and Arg1 indicated M2 macrophage polarization in the GelMA/Eu-HAp groupNo signs of infectionGradual degradation of GelMA/Eu-HAp hydrogel observed over timeJin et al. (2024)

Experimental models and methods in vivo studies.

Histological assessments across various studies frequently highlighted improved tissue integration. A GTU-Fe/KGN@PDA/miRNA@CaP scaffold led to enhanced chondrogenic and osteogenic marker expression, indicating successful differentiation and maturation of regenerated tissue, with elevated glycosaminoglycans (GAG) and collagen deposition contributing to effective cartilage and bone regeneration (Table 4) (Kang et al., 2024). Further corroborating these findings, a Zn-AlgMA@Mg scaffold achieved significant osteochondral integration, facilitating seamless cartilage repair and trabecular bone formation within femoral condyle defects in rabbits (Zhang et al., 2024) (Table 4). Despite these advancements, scaffold-cartilage integration remains a significant challenge in tissue engineering. Recent strategies to address this issue include manipulating cellular, material, and biomolecular composition of engineered tissue (Jelodari et al., 2022). These findings highlight the potential for improved cartilage repair and integration using advanced scaffolds and tissue engineering techniques.

Many studies achieved substantial subchondral bone regeneration, suggesting that functionalization strategies including the incorporation of miRNAs, bioactive molecules, and structurally adaptive hydrogels play a crucial role in promoting dual regeneration for osteochondral repair. For example, bi-layer hydrogels and trilayered scaffolds demonstrated enhanced bone volume and trabecular thickness, ultimately supporting comprehensive osteochondral regeneration (Lan et al., 2021; Chen et al., 2024). Moreover, these studies predominantly used femoral condyle defect models, effectively showing that nano-hydrogels, when tailored to recreate the native extracellular environment, support robust tissue regeneration over extended periods. Functionalization strategies, such as incorporating tissue-specific peptides or drugs, have shown enhanced chondrogenesis and osteogenesis both in vitro and in vivo (Guo et al., 2021; Chen et al., 2024). These advanced scaffolds have demonstrated improved bone volume, trabecular thickness, and overall defect filling in femoral condyle defect models, supporting comprehensive osteochondral regeneration (Cao et al., 2024; Chen et al., 2024; Guo et al., 2024).

The variability in regenerative outcomes observed across studies, characterized by differing degrees of bone density and cartilage smoothness, highlights the necessity for a standardized approach to evaluating scaffold performance. Future research should focus on adopting consistent animal models, such as femoral defect models, and harmonized assessment criteria, such as specific histological markers and imaging techniques, to enable comparative evaluations across various hydrogel systems. Such standardization could accelerate the translation of nano-hydrogel-based technologies into clinical settings, supporting more predictable outcomes and broader applicability.

3.6 Key limitations in osteochondral repair studies and prospective innovations

Recent advances in osteochondral tissue engineering have focused on developing scaffolds that support cell growth and tissue regeneration. Scaffold degradation plays a crucial role in the repair process, with different degradation modalities and speeds influencing outcomes (Tortorici et al., 2022). Despite considerable advances in osteochondral repair, several critical limitations remain across studies, as outlined in Table 5. One major challenge involves inconsistent degradation rates in scaffold materials. Achieving a uniform degradation timeline has proven difficult, with some hydrogel systems degrading faster than intended, reducing structural support for newly forming tissue, while others degrade too slowly, limiting cell infiltration and impeding tissue remodeling. For instance, study conducted by Adedoyin et al. noted this inconsistency in their dual-gelation scaffold, where uneven degradation impacted overall regenerative outcomes (Adedoyin et al., 2015). To address this, further research should investigate advanced crosslinking techniques to fine-tune degradation kinetics, ensuring scaffold resorption aligns more closely with native tissue growth.

TABLE 5

LimitationsFuture directionsReferences
No significant enhancement in mechanical properties; lack of long-term studiesOptimize CuTA concentration; conduct long-term in vivo studiesCao et al. (2023)
Incomplete degradation after 12 weeks; mechanical properties do not match natural tissueOptimize hydrogel composition; explore long-term repair outcomesLan et al. (2021)
Study limited to rabbits; need for investigation in larger animals or humansStudy IL-4 mechanisms in osteochondral repair in larger modelsGong et al. (2020)
Study limited to rabbits; larger animal models and longer-term studies neededInvestigate drug release mechanisms; test in larger animalsChen et al. (2024)
Lack of biomechanical testingExpand to larger models and conduct biomechanical testsHu et al. (2024)
Short-term study (4 weeks)Investigate long-term effects; optimize mechanical propertiesYan et al. (2015)
Short-term in vivo study (14 days)Conduct longer-term studies on scaffold degradationKorpayev et al. (2020)
Short-term studyOptimize materials for cartilage and bone regeneration ratesZhang et al. (2022b)
No in vivo testing conductedFocus on in vivo testing for osteochondral repairAdedoyin et al. (2015)
Short-term study (10 weeks)Conduct long-term studies on degradation and integrationZhang et al. (2024)
Short-term study (12 weeks)Investigate long-term effects; optimize scaffolds for human useDeng et al. (2024)
Short study duration; inflammatory response from scaffold #2Assess long-term effects and optimize modifications to reduce inflammationFilová et al. (2020)
Short-term study; no in vivo testingExplore in vivo testing and growth factor deliveryBrown et al. (2024)
Short-term studyFocus on long-term integration and clinical translationLiu et al. (2021a)
Short-term studyOptimize KGN and miRNA-26a delivery for clinical applicationsKang et al. (2024)
Short-term study (12 weeks)Focus on long-term scaffold integration and degradationLi et al. (2023a)
Short-term studyInvestigate long-term integration of the bilayer scaffoldBanihashemian et al. (2024)
No long-term in vivo testingFocus on in vivo regeneration and long-term mechanical performanceZheng et al. (2014)
Long-term effects not assessedStudy long-term regeneration and clinical testingSheng et al. (2022)
Short-term studyInvestigate long-term degradation and regeneration applicationsZheng et al. (2023)
Short-term studyExplore clinical translation for osteochondral defectsWu et al. (2023)
Short-term study (12 weeks)Optimize exosome delivery and test in larger modelsLi et al. (2023b)
Short-term study; long-term effects not assessedExplore long-term integration and optimization of stimulationZhang et al. (2023a)
No long-term in vivo testing; focused on subcutaneous modelsConduct in vivo testing in osteochondral defect modelsYou et al. (2018)
Short-term studyInvestigate long-term tissue integration and scaffold degradationZhang et al. (2023b)
Short-term studyInvestigate long-term degradation and larger animal integrationRadhakrishnan et al. (2018)
Lack of complete tissue regeneration assessmentInvestigate long-term degradation and clinical translationZhang et al. (2021)
No in vivo studies; long-term effects not assessedFocus on in vivo testing and scaffold optimizationKosik-Kozioł et al. (2019)
Short-term study; no long-term assessmentInvestigate long-term degradation and clinical translationXu et al. (2019)
No in vivo studies performedFocus on in vivo testing and full integration for regenerationQin et al. (2020)
Short-term studyFocus on long-term integration and optimization for regenerationLiu et al. (2021b)
No long-term assessment of degradationStudy long-term degradation and clinical applicationsHu et al. (2022)
Short-term study; long-term effects not assessedFocus on long-term integration and optimization for clinical useLi et al. (2022)
Short-term study; no long-term assessmentInvestigate long-term integration and controlled release systemsLiu et al. (2020)
No in vivo dataExplore in vivo testing and clinical translation for repairFan et al. (2021)
Short-term studyInvestigate long-term integration and clinical translationLuo et al. (2022)
Short-term studyFocus on long-term integration and mechanical performanceGan et al. (2019)
No in vivo studyOptimize scaffold for osteochondral repair with in vivo testingCastro et al. (2015)
No long-term studies conductedFocus on long-term degradation and larger model testingShalumon et al. (2016)
Study limited to short-term evaluationExplore long-term integration and clinical translationGuo et al. (2024)
Short-term animal studyOptimize hydrogel composition and test in larger modelsJin et al. (2024)

Summary of study limitations and proposed future directions.

Another prevalent issue is the variability in scaffold mechanical strength, particularly when scaling up for larger defects. Achieving a mechanical resilience that closely mimics native tissue properties remains challenging. Li et al. reported that preserving compressive strength in bilayer scaffolds was difficult over long-term in vivo applications, highlighting a critical need for more durable biomaterials (Li et al., 2023a). Novel scaffold compositions and innovative crosslinked structures could offer the increased load-bearing capacities necessary to provide robust support in osteochondral applications, particularly those involving weight-bearing joints.

Additionally, there is limited long-term in vivo data on the efficacy and safety of these scaffolds. While short-term successes are frequently observed, the potential for chronic inflammation or complications related to scaffold degradation requires longer follow-up. Studies highlight the necessity for prolonged trials to thoroughly assess scaffold stability, biocompatibility, and integration with native tissue structures, all critical for achieving successful clinical translation (Brown et al., 2024; Hu et al., 2024).

To overcome these challenges, future research could focus on innovative materials and scaffold designs. The use of in situ forming hydrogels, which adapt to irregular defect sites during implantation, may enhance scaffold integration (Zheng et al., 2014; Park and Park, 2018; Kang et al., 2024). Smart, stimuli-responsive hydrogels capable of controlled therapeutic release could also support sustained regeneration and more effective clinical outcomes. Additionally, combining nano-hydrogels with synergistic regenerative approaches such as gene therapy, bioelectronics, or cell-based treatments may lead to multifunctional scaffolds that facilitate not only osteogenesis and chondrogenesis but also angiogenesis (Kumar et al., 2022; Chen et al., 2023). Together, these integrated approaches have the potential to advance osteochondral repair, bringing the field closer to scalable, reliable therapeutic solutions.

4 Conclusion

This systematic review underscores the diverse and evolving strategies employed in nano-hydrogel-based scaffolds for osteochondral repair. By systematically stratifying the included studies according to formulation type (injectable vs. preformed), structural design (single-phase, bilayered, trilayered, or gradient), and polymer origin (natural, synthetic, hybrid), we identified key trends linking scaffold architecture to biological performance. Notably, bilayered and trilayered systems that emulate the native osteochondral zonation more effectively support site-specific chondrogenesis and osteogenesis. Similarly, hybrid scaffolds integrating natural and synthetic polymers often demonstrate superior synergy between mechanical strength and bioactivity.

Despite promising preclinical outcomes, translational challenges persist. The field is hindered by variability in fabrication methods, inconsistencies in mechanical robustness and degradation profiles, and a lack of long-term in vivo validation. Moreover, the absence of standardized animal models and outcome measures limits direct comparison across studies, thereby impeding regulatory progression and clinical adoption.

To address these limitations, we propose a scaffold design framework emphasizing biomimetic zoning, controlled delivery of bioactive cues, stimuli-responsive behavior, and compliance with good manufacturing practice (GMP) standards. Comparative evaluations using unified scoring systems, load-bearing models, and long-term functional assessments will be critical to bridge the gap between laboratory innovation and clinical implementation.

In conclusion, while nano-hydrogels offer clear advantages in mimicking the extracellular matrix and modulating the local microenvironment, their future lies in rational design guided by translational benchmarks. With sustained interdisciplinary collaboration and regulatory foresight, these systems have the potential to evolve into clinically viable, patient-specific therapies for osteochondral regeneration.

Statements

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Author contributions

AFA: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Resources, Writing – original draft, Writing – review and editing. LQ: Conceptualization, Formal Analysis, Investigation, Resources, Writing – review and editing. HD: Formal Analysis, Investigation, Methodology, Resources, Writing – review and editing. JL: Formal Analysis, Investigation, Methodology, Writing – review and editing. JW: Formal Analysis, Supervision, Writing – review and editing. WW: Supervision, Writing – review and editing. JH: Supervision, Writing – review and editing.

Funding

The author(s) declare that no financial support was received for the research and/or publication of this article.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fbioe.2025.1611522/full#supplementary-material

References

  • 1

    AdedoyinA.KumarR.SridharS.EkenseairA. (2015). Injectable bionanocomposite hybrid scaffolds with responsive control for enhanced osteochondral tissue regeneration. IEEE, Troy, NY, USA, 12.

  • 2

    AhmadZ.SalmanS.KhanS. A.AminA.RahmanZ. U.Al-GhamdiY. O.et al (2022). Versatility of hydrogels: from synthetic strategies, classification, and properties to biomedical applications. Gels8 (3), 167. 10.3390/gels8030167

  • 3

    BanihashemianA.Zamanlui BenisiS.HosseinzadehS.ShojaeiS.AbbaszadehH. (2024). Structural and biological investigation of alginate-nano-hydroxyapatite with chitosan-hyaluronic acid for potential osteochondral regeneration. Int. J. Polym. Mater. Polym. Biomaterials73 (10), 851865. 10.1080/00914037.2023.2215378

  • 4

    BerryD. R.DíazB. K.Durand-SilvaA.SmaldoneR. A. (2019). Radical free crosslinking of direct-write 3D printed hydrogels through a base catalyzed thiol-Michael reaction. Polym. Chem.10 (44), 59795984. 10.1039/c9py00953a

  • 5

    BradyM. A.TalvardL.VellaA.EthierC. R. (2017). Bio‐inspired design of a magnetically active trilayered scaffold for cartilage tissue engineering. J. tissue Eng. Regen. Med.11 (4), 12981302. 10.1002/term.2106

  • 6

    BrownN. E.EllerbeL. R.HollisterS. J.TemenoffJ. S. (2024). Development and characterization of heparin-containing Hydrogel/3D-Printed scaffold composites for craniofacial reconstruction. Ann. Biomed. Eng.52, 22872307. 10.1007/s10439-024-03530-z

  • 7

    CaoD.DingJ. (2022). Recent advances in regenerative biomaterials. Regen. Biomater.9, rbac098. 10.1093/rb/rbac098

  • 8

    CaoY.ZhangH.QiuM.ZhengY.ShiX.YangJ. (2024). Biomimetic injectable and bilayered hydrogel scaffold based on collagen and chondroitin sulfate for the repair of osteochondral defects. Int. J. Biol. Macromol.257, 128593. 10.1016/j.ijbiomac.2023.128593

  • 9

    CaoZ.WangH.ChenJ.ZhangY.MoQ.ZhangP.et al (2023). Silk-based hydrogel incorporated with metal-organic framework nanozymes for enhanced osteochondral regeneration. Bioact. Mater.20, 221242. 10.1016/j.bioactmat.2022.05.025

  • 10

    CastroN. J.PatelR.ZhangL. G. (2015). Design of a novel 3D printed bioactive nanocomposite scaffold for improved osteochondral regeneration. Cell. Mol. Bioeng.8, 416432. 10.1007/s12195-015-0389-4

  • 11

    CavendishP. A.EverhartJ. S.PetersN. J.SommerfeldtM. F.FlaniganD. C. (2019). Osteochondral allograft transplantation for knee cartilage and osteochondral defects: a review of indications, technique, rehabilitation, and outcomes. JBJS Rev.7 (6), e7. 10.2106/jbjs.rvw.18.00123

  • 12

    ChahlaJ.SweetM. C.OkorohaK. R.NwachukwuB. U.HinckelB.FarrJ.et al (2019). Osteochondral allograft transplantation in the patellofemoral joint: a systematic review. Am. J. sports Med.47 (12), 30093018. 10.1177/0363546518814236

  • 13

    ChanderS.KulkarniG. T.DhimanN.KharkwalH. (2021). Protein-based nanohydrogels for bioactive delivery. Front. Chem.9, 573748. 10.3389/fchem.2021.573748

  • 14

    ChenH.HuangJ.LiX.ZhaoW.HuaY.SongZ.et al (2024). Trilayered biomimetic hydrogel scaffolds with dual-differential microenvironment for articular osteochondral defect repair. Mater. Today Bio26, 101051. 10.1016/j.mtbio.2024.101051

  • 15

    ChenW.MingY.WangM.HuangM.LiuH.HuangY.et al (2023). Nanocomposite hydrogels in regenerative medicine: applications and challenges. Macromol. Rapid Commun.44 (15), 2300128. 10.1002/marc.202300128

  • 16

    DavisS.RoldoM.BlunnG.TozziG.RoncadaT. (2021). Influence of the mechanical environment on the regeneration of osteochondral defects. Front. Bioeng. Biotechnol.9, 603408. 10.3389/fbioe.2021.603408

  • 17

    De Leon-OlivaD.BoaruD. L.Perez-ExpositoR. E.Fraile-MartinezO.García-MonteroC.DiazR.et al (2023). Advanced hydrogel-based strategies for enhanced bone and cartilage regeneration: a comprehensive review. Gels9 (11), 885. 10.3390/gels9110885

  • 18

    DengC.QinC.LiZ.LuL.TongY.YuanJ.et al (2024). Diatomite-incorporated hierarchical scaffolds for osteochondral regeneration. Bioact. Mater.38, 305320. 10.1016/j.bioactmat.2024.05.004

  • 19

    DinoroJ.MaherM.TalebianS.JafarkhaniM.MehraliM.OriveG.et al (2019). Sulfated polysaccharide-based scaffolds for orthopaedic tissue engineering. Biomaterials214, 119214. 10.1016/j.biomaterials.2019.05.025

  • 20

    DongZ.YuanQ.HuangK.XuW.LiuG.GuZ. (2019). Gelatin methacryloyl (GelMA)-based biomaterials for bone regeneration. RSC Adv.9 (31), 1773717744. 10.1039/c9ra02695a

  • 21

    FanZ.ChenZ.ZhangH.NieY.XuS. (2021). Gradient mineralized and porous double‐network hydrogel effectively induce the differentiation of BMSCs into osteochondral tissue in vitro for potential application in cartilage repair. Macromol. Biosci.21 (3), 2000323. 10.1002/mabi.202000323

  • 22

    FilováE.TonarZ.LukášováV.BuzgoM.LitvinecA.RampichováM.et al (2020). Hydrogel containing anti-CD44-labeled microparticles, guide bone tissue formation in osteochondral defects in rabbits. Nanomaterials10 (8), 1504. 10.3390/nano10081504

  • 23

    GanD.WangZ.XieC.WangX.XingW.GeX.et al (2019). Mussel‐inspired tough hydrogel with in situ nanohydroxyapatite mineralization for osteochondral defect repair. Adv. Healthc. Mater.8 (22), 1901103. 10.1002/adhm.201901103

  • 24

    GeckilH.XuF.ZhangX.MoonS.DemirciU. (2010). Engineering hydrogels as extracellular matrix mimics. Nanomedicine5 (3), 469484. 10.2217/nnm.10.12

  • 25

    GongL.LiJ.ZhangJ.PanZ.LiuY.ZhouF.et al (2020). An interleukin-4-loaded bi-layer 3D printed scaffold promotes osteochondral regeneration. Acta Biomater.117, 246260. 10.1016/j.actbio.2020.09.039

  • 26

    GoughJ. E.SaianiA.MillerA. F. (2012). Peptide hydrogels: mimicking the extracellular matrix. Bioinspired, Biomim. Nanobiomaterials1 (1), 412. 10.1680/bbn.11.00007

  • 27

    GuoC.SuZ.ZhaoL.ChenR.WangY.WuY.et al (2024). Customized triphasic cartilage composite scaffold simulating hypoxic microenvironment for osteochondral regeneration. Compos. Part B Eng.271, 111161. 10.1016/j.compositesb.2023.111161

  • 28

    GuoJ. L.KimY. S.KoonsG. L.LamJ.NavaraA. M.BarriosS.et al (2021). Bilayered, peptide-biofunctionalized hydrogels for in vivo osteochondral tissue repair. Acta Biomater.128, 120129. 10.1016/j.actbio.2021.04.038

  • 29

    GuoJ. L.LiA.KimY. S.XieV. Y.SmithB. T.WatsonE.et al (2020). Click functionalized, tissue‐specific hydrogels for osteochondral tissue engineering. J. Biomed. Mater. Res. Part A108 (3), 684693. 10.1002/jbm.a.36848

  • 30

    HamedE.LeeY.JasiukI. (2010). Multiscale modeling of elastic properties of cortical bone. Acta Mech.213 (1), 131154. 10.1007/s00707-010-0326-5

  • 31

    HjelleK.SolheimE.StrandT.MuriR.BrittbergM. (2002). Articular cartilage defects in 1,000 knee arthroscopies. Arthrosc. J. Arthrosc. and Relat. Surg.18 (7), 730734. 10.1053/jars.2002.32839

  • 32

    HuC.HuangR.XiaJ.HuX.XieD.JinY.et al (2024). A nanozyme-functionalized bilayer hydrogel scaffold for modulating the inflammatory microenvironment to promote osteochondral regeneration. J. nanobiotechnology22 (1), 445. 10.1186/s12951-024-02723-x

  • 33

    HuW.WangZ.XiaoY.ZhangS.WangJ. (2019). Advances in crosslinking strategies of biomedical hydrogels. Biomaterials Sci.7 (3), 843855. 10.1039/c8bm01246f

  • 34

    HuX.ZhengS.ZhangR.WangY.JiaoZ.LiW.et al (2022). Dynamic process enhancement on chitosan/gelatin/nano-hydroxyapatite-bone derived multilayer scaffold for osteochondral tissue repair. Biomater. Adv.133, 112662. 10.1016/j.msec.2022.112662

  • 35

    HwangH. S.LeeC.-S. (2024). Nanoclay-composite hydrogels for bone tissue engineering. Gels10 (8), 513. 10.3390/gels10080513

  • 36

    JelodariS.Ebrahimi SadrabadiA.ZareiF.JahangirS.AzamiM.SheykhhasanM.et al (2022). New insights into cartilage tissue engineering: improvement of tissue‐scaffold integration to enhance cartilage regeneration. BioMed Res. Int.2022 (1), 7638245. 10.1155/2022/7638245

  • 37

    JinY.ShuM.LiuZ.LiH.LiuC.ZhuC.et al (2024). Bio-functional immunomodulatory europium-doped hydroxyapatite nanorods for osteochondral repair via CDH5-RAS-RAF-MEK-ERK-CSF1 axis. Chem. Eng. J.484, 149311. 10.1016/j.cej.2024.149311

  • 38

    KangJ.LiY.QinY.HuangZ.WuY.SunL.et al (2024). In situ deposition of drug and gene nanoparticles on a patterned supramolecular hydrogel to construct a directionally osteochondral plug. Nano-Micro Lett.16 (1), 18. 10.1007/s40820-023-01228-w

  • 39

    KorpayevS.KaygusuzG.ŞenM.OrhanK.OtoÇ.KarakeçiliA. (2020). Chitosan/Collagen based biomimetic osteochondral tissue constructs: a growth factor-free approach. Int. J. Biol. Macromol.156, 681690. 10.1016/j.ijbiomac.2020.04.109

  • 40

    Kosik-KoziołA.CostantiniM.MrózA.IdaszekJ.HeljakM.JaroszewiczJ.et al (2019). 3D bioprinted hydrogel model incorporating β-tricalcium phosphate for calcified cartilage tissue engineering. Biofabrication11 (3), 035016. 10.1088/1758-5090/ab15cb

  • 41

    KumarA.SoodA.SinghmarR.MishraY. K.ThakurV. K.HanS. S. (2022). Manufacturing functional hydrogels for inducing angiogenic–osteogenic coupled progressions in hard tissue repairs: prospects and challenges. Biomaterials Sci.10 (19), 54725497. 10.1039/d2bm00894g

  • 42

    LanW.XuM.QinM.ChengY.ZhaoY.HuangD.et al (2021). Physicochemical properties and biocompatibility of the bi-layer polyvinyl alcohol-based hydrogel for osteochondral tissue engineering. Mater. and Des.204, 109652. 10.1016/j.matdes.2021.109652

  • 43

    LeeJ. H. (2018). Injectable hydrogels delivering therapeutic agents for disease treatment and tissue engineering. Biomaterials Res.22 (1), 27. 10.1186/s40824-018-0138-6

  • 44

    LiC.ZhangW.NieY.JiangD.JiaJ.ZhangW.et al (2023a). Integrated and bifunctional bilayer 3D printing scaffold for osteochondral defect repair. Adv. Funct. Mater.33 (20), 2214158. 10.1002/adfm.202214158

  • 45

    LiM.SongP.WangW.XuY.LiJ.WuL.et al (2022). Preparation and characterization of biomimetic gradient multi-layer cell-laden scaffolds for osteochondral integrated repair. J. Mater. Chem. B10 (22), 41724188. 10.1039/d2tb00576j

  • 46

    LiQ.YuH.ZhaoF.CaoC.WuT.FanY.et al (2023b). 3D printing of microenvironment‐specific bioinspired and exosome‐reinforced hydrogel scaffolds for efficient cartilage and subchondral bone regeneration. Adv. Sci.10 (26), 2303650. 10.1002/advs.202303650

  • 47

    LiuK.LiuY.DuanZ.MaX.FanD. (2021a). A biomimetic bi-layered tissue engineering scaffolds for osteochondral defects repair. Sci. China Technol. Sci.64 (4), 793805. 10.1007/s11431-020-1597-4

  • 48

    LiuP.LiM.YuH.FangH.YinJ.ZhuD.et al (2021b). Biphasic CK2. 1-coated β-glycerophosphate chitosan/LL37-modified layered double hydroxide chitosan composite scaffolds enhance coordinated hyaline cartilage and subchondral bone regeneration. Chem. Eng. J.418, 129531. 10.1016/j.cej.2021.129531

  • 49

    LiuX.ChenY.MaoA. S.XuanC.WangZ.GaoH.et al (2020). Molecular recognition-directed site-specific release of stem cell differentiation inducers for enhanced joint repair. Biomaterials232, 119644. 10.1016/j.biomaterials.2019.119644

  • 50

    LiuY.HsuS.-H. (2018). Synthesis and biomedical applications of self-healing hydrogels. Front. Chem.6, 449. 10.3389/fchem.2018.00449

  • 51

    LowenJ. M.WheelerE. E.ShimamotoN. K.Ramos‐RodriguezD. H.GriffinK. H.BondG. C.et al (2024). Functionalized annealed microgels for spatial control of osteogenic and chondrogenic differentiation. Adv. Funct. Mater.34, 2311017. 10.1002/adfm.202311017

  • 52

    LuoM.ChenM.BaiJ.ChenT.HeS.PengW.et al (2022). A bionic composite hydrogel with dual regulatory functions for the osteochondral repair. Colloids Surfaces B Biointerfaces219, 112821. 10.1016/j.colsurfb.2022.112821

  • 53

    LynchC. R.KondiahP. P.ChoonaraY. E. (2021). Advanced strategies for tissue engineering in regenerative medicine: a biofabrication and biopolymer perspective. Molecules26 (9), 2518. 10.3390/molecules26092518

  • 54

    MacleodM. R.O’collinsT.HowellsD. W.DonnanG. A. (2004). Pooling of animal experimental data reveals influence of study design and publication bias. Stroke35 (5), 12031208. 10.1161/01.str.0000125719.25853.20

  • 55

    ManoJ.ReisR. (2007). Osteochondral defects: present situation and tissue engineering approaches. J. tissue Eng. Regen. Med.1 (4), 261273. 10.1002/term.37

  • 56

    MartinI.MiotS.BarberoA.JakobM.WendtD. (2007). Osteochondral tissue engineering. J. biomechanics40 (4), 750765. 10.1016/j.jbiomech.2006.03.008

  • 57

    MoherD.LiberatiA.TetzlaffJ.AltmanD. G.PrismaG. T. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med.151 (4), 264269. 10.7326/0003-4819-151-4-200908180-00135

  • 58

    MoherD.ShamseerL.ClarkeM.GhersiD.LiberatiA.PetticrewM.et al (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev.4, 19. 10.1186/2046-4053-4-1

  • 59

    NguyenL. H.KudvaA. K.SaxenaN. S.RoyK. (2011). Engineering articular cartilage with spatially-varying matrix composition and mechanical properties from a single stem cell population using a multi-layered hydrogel. Biomaterials32 (29), 69466952. 10.1016/j.biomaterials.2011.06.014

  • 60

    ParkK. M.ParkK. D. (2018). In situ cross-linkable hydrogels as a dynamic matrix for tissue regenerative medicine. Tissue Eng. Regen. Med.15, 547557. 10.1007/s13770-018-0155-5

  • 61

    PaulA.ManoharanV.KrafftD.AssmannA.UquillasJ. A.ShinS. R.et al (2016). Nanoengineered biomimetic hydrogels for guiding human stem cell osteogenesis in three dimensional microenvironments. J. Mater. Chem. B4 (20), 35443554. 10.1039/c5tb02745d

  • 62

    QiaoZ.LianM.HanY.SunB.ZhangX.JiangW.et al (2021). Bioinspired stratified electrowritten fiber-reinforced hydrogel constructs with layer-specific induction capacity for functional osteochondral regeneration. Biomaterials266, 120385. 10.1016/j.biomaterials.2020.120385

  • 63

    QinY.LiG.WangC.ZhangD.ZhangL.FangH.et al (2020). Biomimetic bilayer scaffold as an incubator to induce sequential chondrogenesis and osteogenesis of adipose derived stem cells for construction of osteochondral tissue. ACS Biomaterials Sci. and Eng.6 (5), 30703080. 10.1021/acsbiomaterials.0c00200

  • 64

    QuaziM. Z.ParkN. (2022). Nanohydrogels: advanced polymeric nanomaterials in the era of nanotechnology for robust functionalization and cumulative applications. Int. J. Mol. Sci.23 (4), 1943. 10.3390/ijms23041943

  • 65

    RadhakrishnanJ.ManigandanA.ChinnaswamyP.SubramanianA.SethuramanS. (2018). Gradient nano-engineered in situ forming composite hydrogel for osteochondral regeneration. Biomaterials162, 8298. 10.1016/j.biomaterials.2018.01.056

  • 66

    RanaM. M.De La Hoz SieglerH. (2024). Evolution of hybrid hydrogels: next-generation biomaterials for drug delivery and tissue engineering. Gels10 (4), 216. 10.3390/gels10040216

  • 67

    SethiS.MedhaT. S.SinghA.KaithB. S.KhullarS. (2023). Handbook of green and sustainable nanotechnology: fundamentals, developments and applications. Springer Nature, 131.

  • 68

    ShalumonK.SheuC.FongY. T.LiaoH.-T.ChenJ.-P. (2016). Microsphere-based hierarchically juxtapositioned biphasic scaffolds prepared from poly (lactic-co-glycolic acid) and nanohydroxyapatite for osteochondral tissue engineering. Polymers8 (12), 429. 10.3390/polym8120429

  • 69

    ShengR.ChenJ.WangH.LuoY.LiuJ.ChenZ.et al (2022). Nanosilicate‐reinforced silk fibroin hydrogel for endogenous regeneration of both cartilage and subchondral bone. Adv. Healthc. Mater.11 (17), 2200602. 10.1002/adhm.202200602

  • 70

    SoniS. S.D'eliaA. M.AlsasaA.ChoS.TylekT.O'brienE. M.et al (2022). Sustained release of drug-loaded nanoparticles from injectable hydrogels enables long-term control of macrophage phenotype. Biomaterials Sci.10 (24), 69516967. 10.1039/d2bm01113a

  • 71

    SuvarnapathakiS.WuX.LantiguaD.NguyenM. A.Camci‐UnalG. (2020). Hydroxyapatite‐incorporated composite gels improve mechanical properties and bioactivity of bone scaffolds. Macromol. Biosci.20 (10), 2000176. 10.1002/mabi.202000176

  • 72

    TomalW.OrtylJ. (2020). Water-soluble photoinitiators in biomedical applications. Polymers12 (5), 1073. 10.3390/polym12051073

  • 73

    TortoriciM.PetersenA.DudaG. N.ChecaS. (2022). The degradation of synthetic polymeric scaffolds with strut-like architecture influences the mechanics-dependent repair process of an osteochondral defect in silico. Front. Bioeng. Biotechnol.10, 846665. 10.3389/fbioe.2022.846665

  • 74

    VerhagenR. A.StruijsP. A.BossuytP. M.Van DijkC. N. (2003). Systematic review of treatment strategies for osteochondral defects of the talar dome. Foot ankle Clin.8 (2), 233242. 10.1016/s1083-7515(02)00064-5

  • 75

    VilelaC.CorreiaC.OliveiraJ. M.SousaR. A.Espregueira-MendesJ.ReisR. L. (2015). Cartilage repair using hydrogels: a critical review of in vivo experimental designs. ACS Biomaterials Sci. and Eng.1 (9), 726739. 10.1021/acsbiomaterials.5b00245

  • 76

    WangH.HuB.LiH.FengG.PanS.ChenZ.et al (2022a). Biomimetic mineralized hydroxyapatite nanofiber-incorporated methacrylated gelatin hydrogel with improved mechanical and osteoinductive performances for bone regeneration. Int. J. NanomedicineVol. 17, 15111529. 10.2147/ijn.s354127

  • 77

    WangS.QiuY.QuL.WangQ.ZhouQ. (2022b). Hydrogels for treatment of different degrees of osteoarthritis. Front. Bioeng. Biotechnol.10, 858656. 10.3389/fbioe.2022.858656

  • 78

    WeiG.MaP. X. (2008). Nanostructured biomaterials for regeneration. Adv. Funct. Mater.18 (22), 35683582. 10.1002/adfm.200800662

  • 79

    WuH.ShangY.SunW.OuyangX.ZhouW.LuJ.et al (2023). Seamless and early gap healing of osteochondral defects by autologous mosaicplasty combined with bioactive supramolecular nanofiber-enabled gelatin methacryloyl (BSN-GelMA) hydrogel. Bioact. Mater.19, 88102. 10.1016/j.bioactmat.2022.03.038

  • 80

    XiangC.ZhangX.ZhangJ.ChenW.LiX.WeiX.et al (2022). A porous hydrogel with high mechanical strength and biocompatibility for bone tissue engineering. J. Funct. Biomaterials13 (3), 140. 10.3390/jfb13030140

  • 81

    XuJ.FengQ.LinS.YuanW.LiR.LiJ.et al (2019). Injectable stem cell-laden supramolecular hydrogels enhance in situ osteochondral regeneration via the sustained co-delivery of hydrophilic and hydrophobic chondrogenic molecules. Biomaterials210, 5161. 10.1016/j.biomaterials.2019.04.031

  • 82

    YanL.-P.Silva-CorreiaJ.OliveiraM. B.VilelaC.PereiraH.SousaR. A.et al (2015). Bilayered Silk/silk-nanoCaP scaffolds for osteochondral tissue engineering: in vitro and in vivo assessment of biological performance. Acta Biomater.12, 227241. 10.1016/j.actbio.2014.10.021

  • 83

    YangW.ZhuP.HuangH.ZhengY.LiuJ.FengL.et al (2019). Functionalization of novel theranostic hydrogels with kartogenin-grafted USPIO nanoparticles to enhance cartilage regeneration. ACS Appl. Mater. and interfaces11 (38), 3474434754. 10.1021/acsami.9b12288

  • 84

    YangY.XuT.ZhangQ.PiaoY.BeiH. P.ZhaoX. (2021). Biomimetic, stiff, and adhesive periosteum with osteogenic–angiogenic coupling effect for bone regeneration. Small17 (14), 2006598. 10.1002/smll.202006598

  • 85

    YaoH.WangC.ZhangY.WanY.MinQ. (2023). Manufacture of bilayered composite hydrogels with strong, elastic, and tough properties for osteochondral repair applications. Biomimetics8 (2), 203. 10.3390/biomimetics8020203

  • 86

    YouB.LiQ.DongH.HuangT.CaoX.LiaoH. (2018). Bilayered HA/CS/PEGDA hydrogel with good biocompatibility and self-healing property for potential application in osteochondral defect repair. J. Mater. Sci. and Technol.34 (6), 10161025. 10.1016/j.jmst.2017.11.016

  • 87

    YueS.HeH.LiB.HouT. (2020). Hydrogel as a biomaterial for bone tissue engineering: a review. Nanomaterials10 (8), 1511. 10.3390/nano10081511

  • 88

    ZenginA.CastroJ.HabibovicP.Van RijtS. (2021). Injectable, self-healing mesoporous silica nanocomposite hydrogels with improved mechanical properties. Nanoscale13 (2), 11441154. 10.1039/d0nr07406c

  • 89

    ZhangH.HuangH.HaoG.ZhangY.DingH.FanZ.et al (2021). 3D printing hydrogel scaffolds with nanohydroxyapatite gradient to effectively repair osteochondral defects in rats. Adv. Funct. Mater.31 (1), 2006697. 10.1002/adfm.202006697

  • 90

    ZhangH.LiQ.XuX.ZhangS.ChenY.YuanT.et al (2022a). Functionalized microscaffold–hydrogel composites accelerating osteochondral repair through endochondral ossification. ACS Appl. Mater. and interfaces14 (47), 5259952617. 10.1021/acsami.2c12694

  • 91

    ZhangL.DaiW.GaoC.WeiW.HuangR.ZhangX.et al (2023a). Multileveled hierarchical hydrogel with continuous biophysical and biochemical gradients for enhanced repair of full‐thickness osteochondral defect. Adv. Mater.35 (19), 2209565. 10.1002/adma.202209565

  • 92

    ZhangP.ChenJ.SunY.CaoZ.ZhangY.MoQ.et al (2023b). A 3D multifunctional bi-layer scaffold to regulate stem cell behaviors and promote osteochondral regeneration. J. Mater. Chem. B11 (6), 12401261. 10.1039/d2tb02203f

  • 93

    ZhangY.DongQ.ZhaoX.SunY.LinX.ZhangX.et al (2024). Honeycomb-like biomimetic scaffold by functionalized antibacterial hydrogel and biodegradable porous Mg alloy for osteochondral regeneration. Front. Bioeng. Biotechnol.12, 1417742. 10.3389/fbioe.2024.1417742

  • 94

    ZhangY.HanY.PengY.LeiJ.ChangF. (2022b). Bionic biphasic composite scaffolds with osteochondrogenic factors for regeneration of full-thickness osteochondral defects. Biomaterials Sci.10 (7), 17131723. 10.1039/d2bm00103a

  • 95

    ZhengL.JiangX.ChenX.FanH.ZhangX. (2014). Evaluation of novel in situ synthesized nano-hydroxyapatite/collagen/alginate hydrogels for osteochondral tissue engineering. Biomed. Mater.9 (6), 065004. 10.1088/1748-6041/9/6/065004

  • 96

    ZhengS.LiD.LiuQ.TangC.HuW.MaS.et al (2023). Surface-modified nano-hydroxyapatite uniformly dispersed on high-porous GelMA scaffold surfaces for enhanced osteochondral regeneration. Int. J. NanomedicineVol. 18, 59075923. 10.2147/ijn.s428965

  • 97

    ZhuD.TongX.TrinhP.YangF. (2018). Mimicking cartilage tissue zonal organization by engineering tissue-scale gradient hydrogels as 3D cell niche. Tissue Eng. Part A24 (1-2), 110. 10.1089/ten.tea.2016.0453

Summary

Keywords

nano-hydrogel, osteochondral repair, tissue engineering, biomaterials, osteochondral

Citation

Amhare AF, Qiao L, Deng H, Lin J, Wang J, Wang W and Han J (2025) The current status of nano-hydrogel preparations for osteochondral repair: Systematic Review. Front. Bioeng. Biotechnol. 13:1611522. doi: 10.3389/fbioe.2025.1611522

Received

14 April 2025

Accepted

23 June 2025

Published

01 July 2025

Volume

13 - 2025

Edited by

Dongxu Ke, Wake Forest University, United States

Reviewed by

Yogendra Pratap Singh, VIT University, India

Miguel Fuentes Chandia, Case Western Reserve University, United States

Updates

Copyright

*Correspondence: Wei Wang, ; Jing Han,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics